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Abstract 
Fibroblast growth factor receptors are encoded by four genes, FGFRl-4, which are 
alternatively spliced to produce a large number of variant isoforms. This project was 
designed to investigate the molecular mechanism of the FGFR-VT+ isoform compared to 
its counterpart FGFR-VT- and the expression of four additional isoforms (FGFR-PS+, 
FGFR-PS-, a-FGFRl and ~-FGFRI). FGFR-VT- and FGFR-VT+ differ only by a 
dipeptide (Val423-Thr424) deletion. FGFR-PS- and FGFR-PS+ differ only by a dipeptide 
(Pro442-Ser443) deletion. a-FGFR and ~-FGFR differ by the inclusion or exclusion of the 
first of the three immunoglobulin-like (lg-like) loops. 
Previous work has shown that overexpression of the VT + form in Xenopus embryos 
resulted in posterior truncations, whereas embryos overexpressing the VT- form 
developed normally. In an effort to elucidate the molecular basis of these deformities, 
expression patterns of Xenopus molecular markers known to be important for the 
development of the anterior-posterior axis were investigated. Of the markers studied 
(BMP-4, Xenopus forkhead, Goosecoid, Mix-1 , Noggin, Xenopus brachyury, Xwnt-8, 
Xenopus posterior), no difference in expression pattern was observed, as determined by 
RT-PCR. 
Expression during early embryonic development of the FGFR variants PS+/PS- and 
o.-FGFRl/~-FGFRI were also examined by RT-PCR. Results suggested that PS-is more 
abundant than PS+ (1 .3-1.8X higher) during early Xenopus development, however by 
stage 11.5 the ratio of PS-/PS+ approaches 1.0. Analysis of the lg variants indicated that 
the a -FGFRl form is the predominant transcript (2.5-4.1 X higher) in early development. 
As development proceeds into tadpole stages, ~-FGFRl shows an increase in expression 
levels approaching that of o.-FGFR1 at the same stage of development, with the ratio of 
a-FGFR1/~-FGFRI approaching 1.0. 
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1.1 Model System: Xenopus laevis 
Chapter 1 
Introduction 
Xenopus laevis, the African clawed frog, has been used as a model system for the 
analysis of early vertebrate development for decades (Deuchar 1975; Jones and Smith 
1999). Xenopus laevis present many features that make it appropriate for use in 
developmental biology studies: the females can be induced to lay large quantities of 
viable eggs both easily and repeatedly; the eggs are large (approximately 1 mm diameter) 
and this is favorable for such procedures as micro-injection and micro-dissection; in vitro 
fertilization using the shredded testes from a sacrificed male Xenopus provides large 
numbers of synchronously developing embryos; the rapid rate of development in 
Xenopufi means that results can be obtained quickly; the yolk supply that each egg 
contains serves as an energy source permits the eggs to be cultured in relatively simple 
salt solutions. Mesoderm induction is the primary developmental process being studied 
in this project, but before describing it in detail, a brief overview of early Xenopus 
development will be presented. 
1.2 Xenopus Development 
An overview of Xenopus /aevis lifecycle is pictorially represented in Figure 1.1. The 
unfertilized egg is already differentiated into an upper, pigmented half known as the 
animal hemisphere and a lower, unpigmented half known as the vegetal hemisphere, 
together forming a radially symmetrical sphere. Following fertilization of the egg by a 
Free-swimming tadpole (stage -151 
..... ~-"""-~ 
--~. 
Tailbud embryo (stage 26) 
41 1~125°C) OayJ 
alter 
terlllltallon 
I 
Egg 
(stage 11 
10 
20 IS 
Neurula 
(stage Hi) 
(dorsal VJeW) 
(stage 12) 
stage 10 
(Secbon) 
Figure 1.1: Life Cycle of Xenopus laevis. The inner scale represents the amount of 
time, in hours and days, required post-fertilization for Xenopus embryos to 
reach the standardized stages of development indicated. when cultured at 
25°C. (from Principles of Development, Lewis Wolpert ( 1998)) 
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sperm (Stage 1) a period of rapid cleavage commences. The cleavages are mitotic cell 
divisions which result in an increase in cell number without cell growth, hence a decrease 
in cell size. After approximately six hours of cell division, the embryo, now known as a 
blastula, has formed a fluid-filled cavity, the blastocoel, located above the larger yolk 
cells of the vegetal hemisphere (Stage 8). The germ layers -ectoderm, endoderm and 
mesoderm are now partly specified. During the next stage of development, gastrulation, 
the cells will undergo rearrangement as to achieve the proper orientation of the germ 
layers, with the endoderm moving inside, the mesoderm taking up the middle layer 
position and the ectoderm covering the entire surface of the embryo. Gastrulation is 
followed by neurulation, the stage during which the nervous system is established and 
other major body systems are specified at their future locations. These other body 
systems develop during the period referred to as organogenesis. Within three days post-
fertilization the embryo has developed into a free-swimming tadpole. Over the course of 
the next fifty to sixty days the tadpole will undergo metamorphosis and develop into an 
adult frog. (Wolpert et at. 1998) 
1.2.1 Fertilization and Post-Fertilization 
Fertilization is achieved when a single sperm penetrates the egg at any point on the 
animal hemisphere, referred to as the Sperm Entry Point (SEP). The SEP defines the 
future dorso-ventral axis of the embryo, with the future dorsal side developing opposite 
the SEP, reviewed in Jones and Smith (1999). The egg has two surface coats around its 
plasma membrane, an inner vitelline membrane and an outer jelly coat. After fertilization 
3 
the vitelline membrane lifts off from the egg surface, a process that allows the egg to 
rotate under the effects of gravity, moving the heavier yolk-laden vegetal hemisphere to 
the bottom. This occurs within fifteen to twenty minutes post-fertilization. Within an 
hour after fertilization, the embryo undergoes "cortical rotation", where a gel-like layer of 
actin filaments and associated materials collectively referred to as the cortex, rotates 
about thirty degrees towards the SEP relative to the inner cytoplasm (Vincent and Gerhart 
1987) (Figure 1.2). 
During cortical rotation the vegetal cortex opposite the SEP moves towards the 
animal pole. This region opposite the SEP becomes the future dorsal side and the SEP 
containing region becomes the future ventral side. The major developmental 
consequence of cortical rotation is the establishment of a signaling center in the vegetal 
region opposite the SEP. Referred to as the "Nieuwkoop Center", after the Dutch 
embryologist by that name, this center directs the dorso-ventral polarity of the blastula. 
1.2.2 Cleavage Stages 
The first cell cleavage occurs about 90 minutes after fertilization, beginning at the 
animal pole and dividing the cell (egg) into left and right halves. Subsequent cleavages 
occur at approximately 30-minute intervals. The second cleavage also begins at the 
animal pole and occurs at a right angle to the initial cleavage, separating the egg into 
dorsal and ventral halves. The third cleavage plane occurs perpendicular to the first two 
and separates the egg along the equatorial region into animal and vegetal halves. During 
these early cleavage stages, a small space forms between the animal and vegetal 
4 
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Figure 1.2: Fertilization and Cortical Rotation. (A) Fertilization indicating the sperm 
entry point (SEP). (B) Cortical layer rotating toward the SEP and 
establishing the Nieuwkoop Center. (adapted from Principles of 
Development, Lewis Wolpert (1998)). 
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hemispheres and becomes larger as cleavages continue to eventually become the 
blastocoel (reviewed in Jones and Smith 1999). 
The period of synchronous cell division lasts for a total of 12 cleavages, which 
corresponds to Nieuwkoop and Faber (1967) stage 8. At this time, known as Mid-
Blastula Transition (MBT), cleavage cycles become asynchronous and slow down 
significantly and are characterized by the onset of cell motility and zygotic transcription 
(Newport and Kirschner 1982; Kimelman et al. 1987). 
1.2.3 Gastrulation 
The blastula stage embryo next enters a period of extensive cellular rearrangement 
termed gastrulation. Gastrulation is first visible when some ofthe endodermal cells of 
the dorsovegetal region change shape and become known as bottle cells. These bottle 
cells involute to form a groove in the blastula known as the blastopore, specifically the 
dorsal lip of the blastopore. The layer of presumptive mesoderm and endoderm starts to 
move into the interior of the blastula, such that the lip forms an arc, a semi-circle and 
finally forms a complete circular blastopore. The first mesodermal cells to migrate are 
those at the dorsal side of the embryo that will give rise to head mesodermal structures. 
These cells migrate under the roof of the blastocoel in a single layer. It is only the 
leading mesodermal cells that migrate, the cells that follow undergo convergent 
extension. This band of presumptive mesodermal cells lie initially around the equatorial 
region of the embryo, they involute through the blastopore, converge into a narrow band 
along the dorsal midline and extend in the antero-posterior direction under the ectoderm 
6 
(Wolpert 1998). As these cells are migrating inward, the cells of the animal hemisphere, 
the pigmented upper half of the embryo, are undergoing epiboly, spreading/overgrowth 
and are converging upon the blastopore (Keller et al. 1992; Wolpert 1998). As all this 
cell movement and internalization proceeds, the blastopore becomes increasingly smaller 
until it is reduced to a slit. This closure of the blastopore is indicative of the end of 
gastrulation. At this point the three germ layers are appropriately positioned, the 
ectoderm (formerly animal hemisphere) now covers the entire external surface, the 
endodermal cells (formerly vegetal hemisphere) are completely internalized and the 
mesoderm (formerly equatorial region) forms a layer between the endoderm and 
ectoderm layers (reviewed in Jones and Smith 1999) (Figure 1.3). The endoderm layer 
will give rise to the lining ofthe gut and organs such as the lungs. The mesoderm will 
develop into notochord, muscle, heart, kidneys and blood-forming tissues. The ectoderm 
will give rise to epidermis and the nervous system. 
1.2.4 Mesoderm Induction 
Mesoderm induction is one of the first inductive interactions to occur in the 
developing vertebrate embryo. The early Xenopus embryo (pre-blastula) consists only of 
two cell types: presumptive ectoderm in the animal hemisphere and presumptive 
endoderm in the vegetal hemisphere. The formation of the third required germ layer, 
mesoderm, is derived from inductive interactions between the two existing cell types. 
Evidence for the origin of mesodermal tissues resulting from inductive interactions was 
achieved through the work ofNieuwkoop and colleagues (Nieuwkoop 1969; Sudarwati 
7 
A B 
Figure 1.3: Organization of the Xenopus laevis earJy embryo. (A) Represents the 
maternally determined Animal and Vegetal hemispheres. (B) Represents the 
germ layer (ectoderm, mesoderm, and endoderm) orientation following 
induction of animal cells by vegetal signaJs. 
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and Nieuwkoop 1971). The work showed that when cultured independently, animal pole 
cells from a blastula stage embryo form epidermal derivatives and the vegetal pole cells 
of the same blastula stage embryo form endodermal derivatives. When the animal and 
vegetal pole cells of a blastula stage embryo are co-cultured, a variety of mesodermal cell 
types are formed (Nieuwkoop 1969; Sudarwati and Nieuwkoop 1971 ). Evidence that 
mesoderm induction is a result of secreted, diffusible molecule(s) and not direct cell-cell 
interactions came from Slack (Slack 1991) while re-examining the animal-vegetal pole 
assay ofNieuwkoop. The co-culturing of animal and vegetal pole cells was repeated 
with the modification of separating the two cell types using a porous membrane ftlter. 
The filter prevented direct cell-cell contacts from forming but was porous and therefore 
permitted soluble molecule(s) to pass through. The results obtained were identical to 
those determined previously by Nieuwkoop. 
An additional contribution to the understanding of mesoderm induction was made in 
the 1970s when it was demonstrated that the type of mesoderm that forms when animal 
and vegetal cells are co-cultured depends on the origin of the vegetal pole cells. 
Boterenbrood and Nieuwkoop (1973) demonstrated, using an axolotl model, that dorsal 
vegetal pole cells from blastula stage embryos induce formation of dorsal mesodermal 
cell types (notochord and muscle) while lateral and ventral vegetal cells induce the 
formation of ventral mesodermal cell types (blood, mesenchyme and mesothelium). 
These findings were subsequently demonstrated in Xenopus models (Dale et al. 1985; 
Dale and Slack 1987). 
9 
1.2.4.1 Three-Signal Model 
The previously described work led to the development of the three-signal model of 
mesoderm induction (Smith and Slack 1983; Slack et al. I 984) (Figure 1.4). In this 
model, the first signal originates from the ventral-vegetal region to induce the marginal 
zone cells above to specify ventral mesodermal tissue types (blood, mesenchyme and 
mesothelium). The second signal, emanating from the dorsal-vegetal region known as 
the N ieuwkoop Centre, induces the marginal zone cells overhead to specify dorsal 
mesodermal tissues (notochord) and results in organizer (Spemann's Organizer) activity 
in this region. Evidence for the first two signals was derived from the work of 
Boterenbrood and Nieuwkoop (1973) and evidence for the existence of the third signal (a 
dorsalizing signal) comes from studies by Slack and Forman (1980) and Dale and Slack 
( 19~7) (Figure 1.4). Their work demonstrated that the dorsal marginal zone tissue of an 
early gastrula formed notochord with some muscle and neural tissue when cultured in 
isolation and the ventral marginal zone tissue formed blood, mesenchyme and 
mesothelium. However, when co-cultured the dorsal tissue continues to form notochord 
while the ventral tissue forms muscle. Therefore, these results establish the presence of a 
third signal emanating from the newly formed dorsal mesoderm (Spemann's Organizer) 
and moving horizontally to exert an effect on ventral mesoderm (Slack and Forman 
1980). 
10 
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Figure 1.4: Three-signal model of mesoderm induction. 
VV: ventral vegetal~ DV: dorsal vegetal; 0: organizer. 
(as depicted in Smith et al. (1989)). 
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1.2.4.2 Mesoderm Inducing Factors 
Mesoderm induction is the first inductive interaction in amphibian development, 
when cells of the marginal zone are signaled to follow different developmental pathways. 
While many years of developmental biology studies led to the formation of the three-
signal model, i.e., that proposed mesoderm induction and subsequent patterning resulted 
from the action/effects of three different inducing factors, it wasn't until J 987 that 
progress was made in determining the chemical nature of these factors. It was at this 
time that Slack et al. (1987) and Kimelman and Kirschner (1987) showed that bFGF 
(FGF-2) displayed mesoderm-inducing activity in vitro. Subsequent to this, FGF 
induction of mesoderm was shown to be concentration dependent, such that at low 
concentrations ventral mesoderm (e.g. mesothelium) is induced, while at high 
concentrations more lateral tissues (eg. muscle) are induced (Slack et al. 1987; Slal:k ~t 
al. 1988). Members of the FGF family are capable of inducing all mesodermal cell types 
except notochord, the most dorsal mesoderm (Godsave et al . 1988), and FGF inducing 
activity can be greatly increased by TGF-~ (Hopwood 1990; Woodland 1989). When 
FGF was shown to have this mesoderm inducing activity it was confidently expected that 
it would function similarly in vivo. However, while Slack's (1991) transfilter experiment 
suggested the factor being sought was secreted and soluble, it also suggested that bFGF 
(FGF-2) was not the factor released from the vegetal cells, as the inclusion of antibodies 
which inhibit bFGF in vitro, did not inhibit the natural signal in vivo. It may still have a 
role in mesoderm induction within the responding tissue, since maintenance of the early 
response gene Brachyury (Xbra) is dependent upon the expression ofFGF (Isaacs et al. 
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1994; Schulte-Merker and Smith 1995). Pownall et al. (1996) have shown that the 
overexpression of eFGF causes the upregulation of the posteriorly expressed genes 
Xcad3 and HoxA7. The biological activity ofeFGF and its expression in the posterior of 
the embryo suggest a potential role for it in patterning the anteroposterior axis (Pownall 
et al. 1996). Evidence also suggests that FGF may be required to function in conjunction 
with derriere for the formation of posterior regions (Sun et al. 1999; Zhang et al. 1998). 
XTC mesoderm inducing factor (XTC-MIF) (Smith 1987; Smith et al. 1988; Rosa et 
al. 1988) is, as the name implies, a mesoderm-inducing factor that is secreted by the 
Xenopus XTC cell line. Smith ( 1987) showed that animal cap explants, when cultured in 
XTC-conditioned medium, differentiated into muscle and notochord tissues. Smith et al. 
(1990) discovered that the active molecule in the XTC-conditioned medium was a 
member of the TGF-~ family, the Xenopus ortholog of Activin A (Smith et al. 1990). 
Although capable of inducing mesoderm in vitro, further work by Schulte-Merker and 
colJeagues (1994) suggested that activin was unlikely to function as an initial mesoderm 
inducer in vivo, as the use of an activin inhibitor did not prevent the formation of 
mesoderm in early embryos. 
The protein ofVgl is another candidate molecule. Vgl is a maternal mRNA that is 
restricted to the vegetal hemisphere (Rebagliati et al. 1985), is a member of the TGF-~ 
family (Weeks and Melton 1987) and shows great similarity to the deduced sequence of 
the decapentaplegic (dpp) gene product of Drosophila, another TGF-P family member 
(Padgett et al. 1987). V g l protein requires proteolytic cleavage to be activated. Several 
groups have shown that activated V g 1 protein, when injected into animal cap ex plants is 
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capable of inducing mesoderm (Kessler and Melton 1994; Forristall et al. 1995; Thomsen 
and Melton 1993). However, it has yet to be determined which regions of the embryo 
contain active Vgt protein endogenously, if any. 
VegT, is localized to the vegetal hemisphere of the mature oocyte and early embryo 
has been shown to be required for vegetal cells of the blastula to produce the endogenous 
vegetal signal(s) that cause animal caps to form mesoderm (Kofron et al. 1999; Zhang et 
al. 1998). As VegT is aT-box transcription factor, and as transcription of zygotic genes 
does not begin until after MBT and therefore mesoderm induction, a more plausible role 
for VegT is in determining mesodermal patterning and not as an initial mesoderm 
induction signal. 
P-catenin was initially identified as a cell membrane associated protein in vertebrate 
cells (Ozawa et al. 1989) and was later shown to be a vertebrate ortholog of the 
Drosophila protein, Armadillo. It was demonstrated in Xenopus embryos that depletion 
of maternal P-catenin results in development without dorsal structures (Heasman et al . 
1994). In Xenopus P-catenin mRNA and protein are maternally present (DeMarais and 
Moon 1992). Therefore P-catenin represents a potential early dorsal determinant 
involved in inducing organizer activity. The developmental process of cortical rotation 
seems to result in the cytoplasmic accumulation of P-catenin in the prospective dorsal 
side of the Xenopus embryo (Larabell et al. 1997) with subsequent nuclear accumulation 
in dorsal blastomeres beginning at the 16-cell stage and lasting until mid-blastula stage 
(Larabell et at. 1997). In the nucleus, P-catenin interacts with Tcf/Lefl proteins to 
activate expression of target genes (Molenaar et al. 1996). 
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The molecules described above represent candidates for the initial mesoderm inducer 
and molecules that are potentially involved in the mesoderm induction process. To date, 
no single molecule or group of molecules has been confirmed as the absolute mesoderm 
induction signal. Taking these and additional molecules into consideration, many models 
have been developed and improved upon to schematically represent the process of 
mesoderm induction, such as that represented in the following section. 
1.2.4.3 Mesoderm Induction - A Theoretical Model 
A considerable amount of effort has gone into identifying molecules that are 
responsible for mesoderm induction in vivo and elucidating the model pathways through 
which they act. As the views on some of the potential molecules and subsequent 
pathways remain controversial, the model presented in Figure 1.5 (adapted from Aguis et 
al. 2000) is representative of a current view of mesoderm induction in Xenopus laevis, but 
is by no means the only accepted view, as the evidence remains open to interpretation. 
Around stage 8 of development, the vegetally localized, maternal T -box transcription 
factor VegT induces the Nodal-related genes Xnr 1, Xnr2 and Xnr4 (Clements et al. 1999). 
The nodal gene, first detected in mouse embryos, encodes a secreted protein of the TGF-P 
superfamily. Several nodal-related genes are expressed in Xenopus laevis embryos, 
Xnrl-6, for which maternal transcripts cannot be detected (reviewed in Tiedemann et al. 
200 1). The maternal TGF-13 factor Vgl may also be required for Xnrl andXnr2 
expression (Agius et al. 2000). The presence ofp-catenin on the dorsal side ofthe 
embryo results in higher expression of Xnr I and Xnr 2 on the same side (Figure 1.5). By 
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stage 9, these hlgher levels of Xnrs, coupled with the presence of ~-catenin, result in the 
induction of dorsal mesoderm, whereas the lower levels in the ventral vegetal region 
result in the induction of ventral mesoderm. These molecules therefore fulfill the 
requirements as signals 1 and 2 of the three-signal model. The third signal deals with 
mesodermal patterning and the formation of a complete complement of mesodermal 
tissues initiated at approximately stage 10 of development (Figure 1.5). A current 
perspective on this signal is that the ventral mesoderm expresses BMP-4 (Dale and Jones 
1999) and Xwnt-8 (Christian and Moon 1993; Hoppler et al. 1996) both of which 
ventralize mesoderm. The Spemann Organizer, as the dorsal mesoderm is known, 
expresses Chordin, Noggin, Follistatin (all BMP inhibitors) and Frizbee, a wnt inhibitor. 
The presence of these molecules in the ventral tissues and their inhibitors in the dorsal 
tissues results in a gradient of activity through the mesoderm, which in turn results in the 
formation of the entire complement of mesodermal tissue. 
The current perspective on the role ofFGF in mesoderm induction suggests it may be 
required in the animal hemisphere as a competence factor for the complete range of 
responses to the vegetal inducing molecules. A dominant-negative form of the Xenopus 
type I FGF receptor was used to show that an FGF signal is required for the full 
induction of mesoderm by activin, with some genes requiring higher levels of FGF 
signaling than others (Cornell and Kimelman 1994). Umbhauer et al. (1995) 
demonstrated in Xenopus that FGF induced activation of MAP kinases is necessary and 
sufficient for mesoderm formation. In 1995, Cornell et al. presented evidence supporting 
a role for maternal FGF as a competence factor at the embryonic equator, interface of the 
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animal and vegetal hemispheres, allowing these cells to form mesoderm in response to an 
activin-type signal emanating from the vegetal hemisphere. LaBonne et al. (1995) used 
MAP kinase phosphatase to inactivate MAP kinase and found it to prevent the induction 
of early and late mesodermal markers by both FGF and activin. This indicated that FGF-
dependent MAP kinase activity plays an important role in establishing the responsiveness 
of embryonic tissues to mesoderm inducers. As reviewed in Isaacs (1997), current data 
suggests that maternally present FGF is required in the animal hemisphere of the early 
blastula to confer sub-threshold stimulation of the tyrosine kinase signal transduction 
pathway. This stimulation leads to the activation of Xbra transcription in the late 
blastula, Xbra then activates eFGF (FGF4) expression in the newly formed mesoderm 
and together these molecules establish an autocatalytic activation loop and play an 
important role in the formation of the mesoderm in the blastula. (Isaacs 1997) Further 
information about the role ofFGF came from studies by Isaacs et al. (1994). These 
authors demonstrated that the overexpression of eFGF in Xenopus embryos during 
gastrula stages results in a phenotype of reduced head and an enlarged posterior 
proctodaeum. Therefore showing that FGF signaling is required for anteroposterior 
patterning of the mesoderm. 
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Stage 8 
VegT, Vgl ~eaten in Xnr 
Stage 9 Stage 10 
Gradient of BMP-4, 
Xwnt-8 (ventral and 
laleral mesoderm) 
Figure 1.5: Model of mesodenn induction at the blastula stage by a dorsal to 
ventral gradient. (adapted from Aguis et al. 2000) 
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1.3 Fibroblast Growth Factors 
Research in the laboratory of Drs. Laura Gillespie and Gary Paterno has focused on 
the molecular role of FGF in regulating cell growth and differentiation. The following 
sections provide information about fibroblast growth factors and components of their 
signal transduction pathway, primarily the FGF cell surface receptor (FGFR). 
To date, fibroblast growth factors (FGFs) constitute a family of twenty-three 
structurally re lated proteins, FGFI-23, in mammals. The name Fibroblast Growth Factor 
is misleading. While some FGFs do indeed stimulate fibroblast proliferation, they induce 
proliferation of many other cells as well, and their actions are more general than 
proliferation. They are a family because they are structurally, but not necessarily 
biologically related. FGF was initially identified as an activity that stimulates the 
proliferation ofNIH3T3 cells (Gospodarwicz 1974). FGFs have since been shown to be 
involved in numerous processes including: developmental induction and differentiation; 
cell growth and migration; bone growth and development; neuronal differentiation; 
angiogenesis; wound healing; tumorigenesis (reviewed in Basilico and Moscatelli 1992; 
Burgess and Maciag 1989). Defining features of the FGF family include a strong affinity 
for heparin and heparin-like glycosarninoglycans (HLGAG) (Burgess and Maciag 1989) 
and a central core of 140 amino acids that fonns a compact cylindrical barrel of twelve 
antiparallel ~-strands (Zhang et al. 1991 ). Historical nomenclature was based on 
biological activity, however the current convention is to describe them as "FGFs" 
followed by a numerical designation (Baird and Klagsbrun 1991 ). Table 1.1 provides a 
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complete list of mammalian fibroblast growth factors and Table 1.2 provides a list of the 
identified Xenopus fibroblast growth factors. 
FGF-1 (acidic FGF) was initially isolated from bovine pituitary extract by 
Gospodarowicz (1975) by its ability to cause proliferation and delayed differentiation of 
myoblasts. It was later rediscovered by its ability to stimulate endothelial cell 
proliferation (reviewed in Gospodarowicz et a/., 1987). FGF -l does not have a signal 
sequence for targeting to the secretory pathway (Jaye et al. 1986), although it does 
contain a nuclear localization motif (Imamura et al. 1990), which appears to be important 
in FGF-1 induced mitogenesis. 
FGF-2 (basic FGF) was first identified in 1974 (Gospodarwicz 1974) for its ability to 
cause proliferation and transformation ofBALB/c 3T3 cells. FGF-2 maintains 55% 
sequence identity with FGF-1, and as with FGF-1, FGF-2 does not contain a signal 
sequence for secretion. 
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Table 1.1: Mammalian Fibroblast Growth Factor fami ly members. 
Current Nomenclature Historical Name Reference 
FGF-1 Acidic FGF (aFGF) Gospodarowicz et al. 1975 
FGF-2 Basic FGF (bFGF) Gospodarowicz et al. 1974 
FGF-3 INT-2 Dickson et al. 1984 
FGF-4 HST-1/kFGF Sakamoto et al. 1986 
FGF-5 
---
Zhan et al. 1988 
FGF-6 HST-2 Maries et al. 1989 
FGF-7 KGF Rubin et al. 1989 
FGF-8 AIGF Tan aka et al. 1 992 
FGF-9 GAF Miyamoto et aJ. 1993 
FGF-10 
---
Y arnasaki et aJ. 1 996 
FGF-1 1 FGF homologous factor - 1 Smallwood et aJ. 1996 
FGF-12 FGF homologous factor - 2 Smallwood et al. 1996 
FGF-13 FGF homologous faclor - 3 Smallwood et al. 1996 
FGF-14 FGF homologous factor -4 Smallwood et al. 1996 
FGF-15 --- Me Whirter et al. 1997 
FGF-16 - Miyake et al. 1998 
FGF-17 --- Hoshikawa et al. 1998 
FGF-18 --- Ohbayashi et al. 1998 
FGF-19 -- Xie et al. 1999 
FGF-20 
---
Ohmachi et al. 2000 
FGF-21 --- Nishimura et al. 2000 
FGF-22 
--- Nakatake et a!. 2001 
FGF-23 
--- Yamashita et al. 2000 
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Table 1.2: Xenopus laevis Fibroblast Growth Factor family members. 
Current Nomenclature Reference 
XFGF-2 Kimelman et al. 1988; Kimelman and Kirschner 1987 
XFGF-3 Tannahill et al. 1992 
XFGF-4 Isaacs et al. 1992 
XFGF-8 Christian and Slack 1997 
XFGF-9 Song and Slack 1996 
XFGF-20 Koga et al. 1999 
1.4 Fibroblast Growth Factor Receptors 
The search for molecules involved in fibroblast growth factor signaling uncovered 
both low and high affinity FGF binding sites on the plasma membrane of cells. 
Fibroblast growth factors bind specifically and with nanomolar affinity (K0=2nM) to 
heparin sulfate proteoglycans and therefore constitute the low affinity binding site 
(Moscatelli 1987; Burgess and Maciag 1989). A group of receptor tyrosine kinases were 
shown to bind FGFs with picomolar affinity (Ko=20pM) and therefore constitute the high 
affinity site for FGFs on the cell surface (Moscatelli 1987; Burgess and Maciag 1989). 
1.4.1 Receptor Tyrosine Kinases - The High-Affmity Fibroblast Growth 
Factor Receptors 
There are presently more than 50 Receptor Tyrosine Kinases (RTKs) that belong to at 
least 13 different receptor families (Fedi and Aaronson 2001). The structural 
characteristics ofRTKs include a glycosylated extracellular ligand-binding domain, a 
single hydrophobic transmembrane region and a cytoplasmic region with a conserved 
tyrosine kinase catalytic domain (Fedi and Aaronson 2001 ; Ullrich and Schlessinger 
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1990; Wilks 1993). Included in this broad category of receptors are the four high-affinity 
Fibroblast Growth Factor Receptors, FGFR1-4. 
There are four known mammalian genes that encode receptor tyrosine kinase FGF 
receptors, referred to as fgfr 1-4 (refer Table 1.2). The gene for FGFR-1 was initially 
described as an fms-like gene (flg) by Ruta et al. (1988) when it was isolated by low 
stringency hybridization using a eDNA probe corresponding to the tyrosine kinase 
domain of the CSF-1 (colony-stimulating factor 1) receptor. It was described as a FGF-2 
receptor when the chicken form of the protein was isolated by FGF-2 affinity 
chromatography (Lee et al. 1989), it has since been shown to bind with high-affinity to 
FGF-1 and FGF-2 (Ruta et al. 1989). The FGFR-2 gene was initially described as 
bacterially expressed kinase (bek), for which a partial eDNA was first isolated by 
phosphotyrosine antibody screening of a mouse liver expression library (Kornbluth et al. 
1988). Full-length eDNA for human and chicken bek were later described (Dionne et al. 
1990; Pasquale 1990; Houssaint et al. 1990) and shown to bind with high-affinity to 
FGF-1 and -2 (Houssaint et al. 1990; Dionne et al. 1990; Mathieu et al. 1995). The third 
known FGFR (FGFR-3) was originally named chicken embryo kinase-2 (CEK-2) as it 
was isolated by phosphotyrosine antibody screening of a chicken embryo expression 
library (Pasquale 1990; Pasquale and Singer 1989) and has been shown to bind both 
FGF-1 and FGF-2 with high-affinity (Mathieu et al. 1995). The most recently identified 
receptor, FGFR-4, was cloned from human erythroleukemia cells (Partanen et al. 1991) 
and was shown to bind FGF-1 with high affinity but not FGF-2 (Partanen et al. 1991). 
eDNA encoding Xenopus orthologs of fibroblast growth factor receptor- I , -2 and -4 have 
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been cloned (Musci et al. 1990; Friesel and Brown 1992; Shiozaki et aL 1995). The 
interactions of the numerous FGFs and the multiple forms of the FGFRs are being widely 
studied, but an in-depth description of the multitude of interactions is beyond the scope of 
this project's research and will not be discussed in this thesis. 
Table 1.3: Fibroblast Growth Factor Receptors 
Numerical Designation Historical Names References 
FGFR-1 Mammalian fig Ruta et al. 1988 
Chicken cek-1 Pasquale 1990 
FGFR-2 murine and human bek Kornbluth et al. 1988 
Dionne et al. 1990 
Chicken cek-3 Pasquale 1990 
FGFR-3 murine fig-2 Avivi et al. 1991 
chicken cek-2 Pasquale 1990 
FGFR-4 
--- Partanen et at. 1991 
1.4.2 Fibroblast growth factor receptor structure 
The high affinity FGFR is a monomeric molecule characterized by the presence of an 
extracellular ligand-binding domain composed of three immunoglobulin-like domains 
(Ig-loops), an acidic box domain between Ig-loops I and II, a transmembrane segment 
that functions to anchor the receptor in the cell membrane, ajuxtamembrane region, and a 
split tyrosine kinase domain (Figure 1.6). The tyrosine kinase domain is the most highly 
conserved region of the receptor molecule. The insert sequence that spli ts the kinase 
domain is highly conserved between species for specific receptors and is believed to 
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regulate interactions between the receptor and cellular substrate proteins. (Reviewed in 
Ullrich and Schlessinger (1990)). 
1.4.3 Multiple forms of FGFR 
Generally speaking, each of the four fibroblast growth factor receptors is capable of 
binding and subsequently being activated by more than one fibroblast growth factor. To 
further enhance and diversify the FGF-FGFR system, each of the four FGFR genes can 
be alternatively spliced to present a number of variant isoforms. One of the well-
documented splice variants includes those that exclude the first of the three lg-like 
domains (Figure 1. 7 A). As mentioned, the primary structure for the FGFR contains an 
extracellular domain with three lg-like loops. It has been shown that an alternative-
splicing event occurs in both FGFR-1 and - 2 that results in receptors with truncated 
extracellular domains (Johnson et al. 1990; Eisemann et al. 1991; Friese} and Dawid 
1991; Musci et al. 1990). These truncated receptors lack the amino-terminal lg-like loop 
(loop I) leading to the formation of a 2 lg-like domain FGFR (Fi.gure 1. 7). The three and 
two lg loop receptor forms have been termed a. and ~ respectively. The functional 
significance of the exclusion of the first Ig loop is uncertain as the truncation does not 
prohibit ligand binding and the receptor appears to function in a normal capacity 
(Chellaiah et al. 1999; Duan et al. 1992; Wang et al. 1995a), however it does appear to 
modulate ligand-binding affinity (Coutts and Gallagher 1995; Wang et al. 1995b). 
Another known splicing event occurs in the carboxy-terminus of the third lg-like domain 
which is encoded by three exons, of which two are alternatively spliced (Johnson and 
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---• PM 
TK1 
TK2 
Figure 1.6: General structure of type 1 fibroblast growth factor receptor. Depicted here 
are the three extracellular immunoglobulin-like domains (I. n, Ill). the 
acidic box (AB), the transmembrane domain (TM) and the intracellular split 
tyrosine kinase domain (TKI and TK2). The transmembrane domain passes 
through the plasma membrane (PM), with the Juxtamembrane (JM) region 
located just inside the PM. 
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TK1 TK2 
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Figure 1.7: Variant forms of FGFRl. (A) a-FGFR, 3 lg form of the receptor~ B-
FGFR, 2 lg form of the receptor. (B) FGFR-Illa, truncated. soluble lbrm 
of the receptor; FGFR-llJb and FGFR-Illc, fully functional receptors \\ ith 
differing FGF binding affinities. (C) FGFR-PS+ and FGFR-PS-, differing 
only by the inclusion or exclusion ofProline_..n_Serine.t43 dipeptide. 
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Williams 1993). The variants that differ in the second half of their third lg loop have 
been termed rna, Illb and lllc respectively and have been shown to differ in their ligand 
binding affinities (Figure I. 7). The FGFR Ilia variant is a truncated soluble form of the 
receptor that cannot transduce an intracellular signal. However, the Ilia receptor variant 
has been demonstrated to bind FGF-2 with a higher affinity than FGF-1, which may 
suggest it functions to sequester released FGFs (Beer et al. 2000). The Illb and Illc 
variants have been shown to dramatically alter the FGF affinity of a given receptor. 
These variants have been described for FGFR I, 2 and 3. In studies utilizing FGFR2-IIIb 
and -lllc, the IIIc variant binds aFGF and bFGF with equal affinity, however the IIIb 
variant binds bFGF with 1000-fold less affinity, aFGF is still bound and it also binds 
KGF (FGF-7) (Dell and Williams 1992; Yayon et al. 1992; Omitz et al. 1996; Beer et al. 
2000). 
1.4.4 FGF-FGFR Interactions/Signaling 
Fibroblast growth factors exert their effects on cells through the binding of the high-
affinity transmembrane receptors that initiates an intracellular signaling cascade. The 
generalized sequence of events involved in the FGF-FGFR signal activation is outlined 
here in Figure 1.8. The FGF binds to its high-affinity receptor and results in receptor 
dimerization. The cytoplasmic domains are brought into close proximity due to the 
dimerization and subsequently autophosphorylate each other's cytoplasmic domains at 
distinct tyrosines. This state of autophosphorylation results in activation of the receptor 
dimer to phosphorylate cytoplasmic substrates and initiate intracellular signaling 
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pathways. (Reviewed in Jaye et al. 1992; van der Geer et al. 1994) (Figure 1.8). These 
pathways include phospholipase C-gamma (PLC-y), Ras and the less well understood 
phosphotidylinositol 3-kinase (PIJK) pathways. 
When PLC-y is activated, it cleaves phosphatidyl-inositol-4,5-bisphosphate (PIP2) 
into inositol triphosphate (IP3) and diacylglycerol (DAG). The IP3 facilitates the release 
of calcium from intraceUular stores that in combination with DAG activates protein 
kinase C (PKC) (Powers et al. 2000), these molecules then activate additional molecules 
and thereby bring about the desired processes such as transcription. 
The Ras pathway is activated by receptor dirnerization and autophosphoryJation. 
Growth factor receptor .Qinding protein~ (Grb2) forms a complex with the cytoplasmic 
molecule ~on Qf ~evenless (SOS), this complex then binds to the phosphotyrosine of the 
receptor through the SH2 domain of Grb2. The receptor Grb2-SOS combination then 
activates Ras. Ras activation then takes the pathway through the subsequent activation of 
Raf, MEK and MAP kinases. The signal has then traveled to the nucleus where MAP 
kinase activates transcription factors via phosphorylation. (Gilbert I 997; Lewin 2000) 
The enzyme PIJK is thought to interact with the phospho tyrosine of an active 
receptor dimer via the p85 subunit of Pl3K. PBK is also shown to act in the FGF 
signaling pathway downstream of Ras and in parallel to the MAP kinase signaling 
(Carballada et al. 2001 ). In general, interaction with the receptor brings PBK into close 
proximity with various membrane phosphoinositols which in turn activate particular 
proteins. Some of the proteins activated by this pathway include: a Ser/Thr kinase, Akt 
(PKB), which is known to activate GSK3; p7056k (p 70 ribosomal S6 kinase) that 
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phosphorylates the S6 protein component of the 40S ribosomal subunit during mitogenic 
responses and may contribute to the regulation of other cellular processes; PKC and PRK 
(fKC-related kinases). (Vanhaesebroeck et al. 1997) 
1.4.5 Xenopus FGFRs 
Three RTK FGFR genes have been cloned in Xenopus, the FGFR-1 gene is expressed 
throughout early Xenopus development (Musci et al. 1990), the FGFR-2 is first detected 
during gastrulation (Friesel and Brown 1992) and FGFR-4 is expressed throughout 
development but in a manner that differs from FGFR-1 and FGFR-2 (Shiozaki et at. 
1995). Two previously cloned isofonns ofXFGFRl in Xenopus include a three lg 
domain XFGFR-A I (Musci et al. 1990) cloned from an oocyte library and a two Ig 
domain XFGf'R-A2 (Friesel and Dawid 1991) cloned from a Xenopus cell line. A 
dominant negative mutant of XFGFR was also produced for Xenopus from Musci' s 
XFGFRI. The mutant, known as XFD contains only intact extracellular and 
transmembrane domains and has been shown to successfully inhibit FGF signaling in the 
Xenopus oocyte (Amaya et al. 1991 ). Amaya et al. used this dominant negative receptor 
to examine the role ofFGF in early Xenopus development. The studies went on to show 
that explants from embryos expressing XFD failed to fonn mesoderm in response to FGF 
and in whole embryos XFD resulted in gastrulation and posterior development defects. 
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Figure 1.8: The signal transduction pathways activated by the binding of two FGFs to 
the FGF receptors. The ras G protein signals the transcription of new 
mRNAs, phospholipase C- gamma (PLC-y) is activated to cleave PIP2 into 
IP3 and DAG, and PI3K sir,ats cellular regulatory molecules. (adapted from 
Developmental Biology, 6L Ed, Scott F Gilbert) 
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While undertaking studies to investigate the molecular mechanisms involved in 
mesoderm induction, through the initial determination of which FGFR genes are involved 
and how FGFR signaling is regulated, the research group of Drs. Laura Gillespie and 
Gary Paterno isolated a eDNA clone that encoded a variant form ofXFGFR, named 
FGFR-VT- (Gillespie et al. 1995). 
1.4.6 Review of FGFR-VT-
Compared structurally to the two previously cloned Xenopus type 1 FGFR, XFGFR-
Al and XFGFR-A2, FGFR-VT- contained a deletion ofVal423-Thr424 (VT) in the 
juxtamembrane region. Through sequencing of the genomic fragment containing the VT 
region and subsequent analysis, it was concluded that the most likely mechanism for the 
production ofthe two isoforms is the use of alternative 5' splice donors (Gillespie et aL 
1995). Potential for amino acid position 424 as a phosphorylation site was investigated 
by in vitro kinase assays using PKA and PKC. Short peptides for both FGFR-VT- (AA 
417-428) and FGFR-VT+ (AA 417-430) were constructed and an in vitro assay revealed 
that neither peptide was phosphorylated by PKA and that the FGFR-VT + (AA 417 -430) 
peptide was phosphorylated by PKC (Gillespie et al. 1995). For comparison, a full-
length FGFR 1 was constructed that contains 3 lg-like domains and Val423- Thr424 and thus 
differs from FGFR-VT- only by the presence ofVal423-Thr424, referred to as FGFR-VT+ 
(Figure 1 . 9). Full-length proteins were both phosphorylated by PKC, but the VT + form 
displayed twice the Jevel of incorporation ofVT- (Gillespie et al. 1995). The spatial and 
temporal expression patterns of VT + and VT- were examined in embryos at stages when 
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mesoderm induction was known to take place. VT- expressed predominantly jn the 
marginal zone (presumptive mesoderm) and VT + expressed throughout the embryo as 
determined by RNase protection assay (Paterno et aJ. 2000). At 4.5 hours post 
fertilization VT + is the major isoform, this switches at 5 hours post fertilization when 
VT- becomes the predomjnant form, then at 5.5 hours post fertilization and all 
subsequent times studied, VT +returns as the predominant form as determined by RT-
PCR. The effect of overexpressing each receptor isoform in Xenopus embryos was 
studied. Control embryos and those overexpressing FGFR-VT- developed normally, 
while less than 10% of those embryos overexpressing FGFR-VT+ developed normally 
(Paterno et al. 2000). The abnormal phenotype, a severe posterior truncation, was similar 
to that resulting from the overexpression of a dominant negative FGFRl, XFD, that 
consists of an extracellular domain, transmembrane domain and the first 7 amino acids of 
the intracellular domain (Figure 1.9) and when overexpressed in embryos, inhibits 
endogenous FGFR (Amaya et al. 1991). Those abnormalities were shown to be the result 
of a reduction in posterior mesoderm development. The effect of VT + and VT-
overexpression on mesoderm formation in vitro was investigated. FGF-2 dose-response 
was measured in explants from embryos overexpressing either VT+ or VT- and compared 
to normal embryos. It was deduced that VT+ overexpressing explants required a 2-fold 
higher concentration of FGF-2, while VT- overexpressing explants required a 5-fold 
lower concentration of FGF-2, than control ex plants to achieve 50% mesoderm induction 
(Paterno et al. 2000). Overexpression of VT + decreased sensitivity to FGF, while 
overexpression ofVT- greatly increased sensitivity, and further examination revealed that 
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Figure 1.9: Structure of the fibroblast growth factor receptor isoforms FGFR-VT+ and 
FGFR-VT- and the dominant-negative FGF receptor XFD. 
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the sensitivity to FGF was directly correlated with the relative expression levels of the 
two isoforms. Thereby demonstrating that VT + can function to negatively regulate 
mesoderm formation and therefore the abnormal phenotype that resulted may have been 
the consequence of a deficiency in mesoderm formation (Paterno et al. 2000). 
1.5 Target Genes of FGF Induction 
The initial response to mesoderm induction is rapid changes in levels of gene 
expression, in particular, genes that encode classes of proteins that are likely to be 
involved in mesodermal differentiation, such as transcription factors and growth factors. 
immediate early response genes represent the frrst genes to be transcribed after a cell or 
population of cells has been stimulated by a growth factor. RNA expression analysis of 
cells that have been treated with growth factor alone or growth factor in the presence of 
protein synthesis inhibitor, such as cycloheximide, is normalJy performed to confirm an 
immediate early gene. Expression of an immediate early target will be induced by 
growth factor in both the absence and presence of cycloheximide, as was shown to be the 
case for Xbra, an immediate early target of FGF signaling (Smith et al. 1991 ). The genes 
that become expressed in response to mesoderm induction therefore double as markers or 
indicators of induction. 
The abnormal phenotype observed for the embryos overexpressing FGFR-VT+ is a 
posterior truncation with normal head development and is the result of a reduction in 
posterior mesoderm. Therefore, part of this project studied the effect of overexpressing 
FGFR-VT+ on the expression patterns of genes expressed in these affected regions. As 
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there are many genes known to be expressed at this time, I started with markers known to 
be affected by XFD, as the VT + phenotype is similar to that produced by overexpression 
of XFD (Paterno et al. 2000). 
Brachyury is aT-box gene required for formation of mesoderm and notochord in 
mouse, the Xenopus ortholog is known as Xbra (Herrmann et al. 1990; Wilkinson et al. 
1990). Through molecular analysis it was revealed that Xbra is an immediate early 
response gene to Activin and FGF (Smith et al. 1991 ) and is maintained by a feedback 
loop with FGF (Isaacs et al. 1994; reviewed in Technau 2001). Xbra is considered an 
excellent marker of early mesoderm as transcripts first appear at MBT, with highest 
levels of expression observed during gastrulation in the presumptive mesodermal cells 
around the blastopore lip (Smith et al. 1991). Overexpression of the dominant-negative 
Xenopus type 1 FGF receptor, XFD, is shown to inhibit expression of brachyury (Amaya 
et al. 1993). Therefore we anticipated seeing a decrease in Xbra expression in our 
analysis. 
Xwnt-8 is a Xenopus Wnt-1-related gene that is expressed in the ventral-lateral 
marginal zone after MBT and is involved in a Wnt pathway required for patterning of the 
mesoderm (Christian and Moon 1993; Christian et al. 1991; Hoppler et al. 1996). This 
gene is expressed in the region of the embryo missing or truncated by VT + 
overexpression, we anticipated a reduction in its expression. 
Bone morphogenetic Qroteins (BMP) are maternally expressed in Xenopus embryos 
(Nishimatsu et al. 1992; Dale et al. 1992). BMP-4 has been shown to induce ventra l 
mesodermal tissues in a standard mesoderm induction assay (Dale et al. 1992; Jones et al. 
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1992). Evidence suggests that BMP signaling is not essential for initial mesoderm 
induction, but is involved in the dorsoventral organization of mesoderm (Graff et al. 
1994). Therefore this gene is involved in patterning the region of the embryo missing or 
truncated by VT + overexpression and we anticipated a reduction in its expression. 
Zygotic expression of noggin occurs at the correct place and time for it to have a role 
in the functions of the Spemann Organizer, which among other things dorsalizes ventral 
mesoderm (Smith and Harland 1992). Noggin protein has been shown to function by 
antagonizing BMP signaling by direct binding to BMP molecules (Smith et al. 1993). 
This gene is expressed in the apparently normally developing region of the VT+ 
overexpressing embryos, we anticipated no change or a possible increase in its 
expression. 
Goosecoid (gsc) is a homeobox gt::nt:: ~hown to encode a DNA-binding protein. The 
gsc gene is expressed in the Spemann organizer of Xenopus embryos as a primary 
response to mesoderm inducing factors (Cho et al. 1991 ). Goosecoid is expressed at the 
right time and place for mesoderm specification and can pattern mesodermal 
differentiation through a concentration gradient (Niehrs et al. 1994). Overexpression of 
the dominant-negative receptor XFD has been shown to have no effect on goosecoid 
expression in Xenopus (Amaya et al. 1993). As the XFO receptor was shown to have no 
effect, we expected a similar result from overexpressing our receptor. 
Mesoderm induced homeobo~ 1 (Mix. !) behaves as an immediate early response to 
induction and the gene encodes a transcription factor (Rosa 1989; Lemaire et al. 1998). It 
has been shown that Mix.J mediates the ventralization effect ofBMP-4 during mesoderm 
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formation (Mead et al. 1996). As this gene is shown to be linked to BMP-4, we 
anticipated seeing a decrease in its expression. 
Keno pus :QQSterior (Xpo) is an immediate early marker of ventral and lateral 
mesoderm that is activated at or shortly after MBT (Sato and Sargent 1991 ; Amaya et al. 
1993). It has been demonstrated that overexpression of the dominant-negative receptor 
XFD, inXenopus, results in an inhibition ofXpo expression (Amaya et al. 1993). As 
XFD was shown to inhibit expression of this gene, we expected a similar result from the 
overexpression of our receptor. 
1.6 Hypotheses and Objectives 
Previous findings demonstrated that FGFR-VT + negatively regulates mesoderm 
formation when overexpressed in Xenopus embryos and results in severe r~uuctions in 
trunk and tail structures. The primary objective of my project was to investigate the 
molecular basis of the abnormal pattern of development observed in the Xenopus 
embryos overexpressing FGFR-VT +. Based on the abnormalities observed in the VT + 
overexpressing embryos, it was hypothesized that distinct misexpression of molecular 
marker(s) known to be required for, or a consequence of, normal mesoderm formation 
would be observed. 
A second objective for this project was to investigate the expression patterns of other 
known FGFRI isoforms and was based on the hypothesis that FGFR isoforms have 
distinct function and therefore would be differentially expressed during embryonic 
development. We examined the temporal and spatial expression of two additional 
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receptor variants. One of these variants ctiffered from the reported sequence by the 
deletion of Proline 442 -Serine 443 (Figure I . 7). We felt this might be of interest as the 
serine residue represents a potential phosphorylation site that may regulate receptor 
function. The other FGF receptor variant involves the extracellular immunoglobulin-like 
(lg) domains. These variants represent the a-form (3 Ig-like domains) and the P-form (2 
lg-like domains) of the fibroblast growth factor receptors that differ by the inclusion or 
exclusion of the first of the three Ig domains. These variants are of interest because they 
may have different ligand binding specificities and affinities. 
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Chapter 2 
Materials and Methods 
2.1 Xenopus laevis: artificially-induced ovulation and in vitro fertilization 
Materials: Xenopus laevis were purchased from Nasco, Fort Atkinson. Wisconsin. 
Methods: Approximately 16 hours prior to the time the eggs were required, female 
Xenopus laevis were given a subcutaneous injection of750 l.U. of Human Chorionic 
Gonadotrophin (Sigma) into the hind leg, just above the cloaca, and held in tanks at room 
temperature. Within 12-18 hours, the females began to lay eggs in their holding tanks. 
During this time period, females were manuaJly stripped of their eggs. These recovered 
eggs were then fertilized in a petri dish using a macerated piece of testes from a sacrificed 
male Xenopus laeivs. The fertilized embryos were chemically dejellied using 2.3% L-
cysteine hydrochloride (pH 7.8-8.1), washed with deionized-distilled water and 
transferred to a petri dish containing NAM/20 Xenopus culture medium (Tables 2.1 and 
2.2). The embryos are then cultured at room temperature. 
Table 2.1: Composition of lOx Normal Amphibian Medium (NAM) Stock 
Salt Per liter of stock 
NaC/ 65 g 
KC/ 1.5 g 
Ca(N03)2·4H20 2.4 g 
MRS04·?H20 2.5 g 
0.5M EDTA (pH 8.0) 2 ml 
I M He pes (pH7. 5) 100 ml 
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Table 2.2: Xenopus Embryo Culture Mediums 
per 100 ml final volume NAM NAM/2 NAM/20 
lOx NAM salts 10 ml 5 ml 0.5 ml 
O.lM NaBicarb 1 ml l ml 1 ml 
Gentamycin (lOmg/ml) 0.25 ml 0.25 ml 0.25 mJ 
Sterile dH20 up to 100 ml up to 100 m1 Up to 100 ml 
2.2 Synthesis ofVT+ and VT- cRNA 
Materials: Ribomax™ Large Scale RNA Production System - SP6 was purchased from 
Promega Corporation, Madison, Wisconsin. 
Method: In vilro transcription reactions were performed as described in the Ribomax™ 
kit insert. 
Template Linearization. The DNA templates (SP64T-VT- and SP64T-VT+) were 
linearized in a reaction using restriction enzyme Xbal. A 50 J!l digestion reaction was 
setup in a I. 7 ml eppendorf tube (containing 5 J.1} lOX REact 2 digestion buffer; 3 J!l XbaJ 
(1 OU/J.tl); 30 J!l DNA template (0.5 J.lg/J.tl); 12 J.tl DEPC-treated water) and was incubated 
at 37°C for 2 hours. 1 !J.l of digested template was then run on a 0. 7% agarose gel to 
ensure complete linearization. 200 J!l DEPC-treated water was then added to each of the 
digestion reaction tubes. This was followed by extraction with equal volume of 
Phenol/ChloroformllAA (Invitrogen). The aqueous phase was transferred to a new 1. 7 
ml eppendorf tube and the linear DNA template was precipitated with 2X the volume of 
ethanol and 1/ 10 the volume of 3M NaOAc at -20°C overnight. The linear DNA template 
was then collected by centrifugation, washed with cold 70% ethanol, dried under vacuum 
and resuspended in 1 50 J!l DEPC-treated water. 
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In vitro Transcription. Transcription reactions were carried out in 100 p.l volumes. 
For each DNA template, a master mix was prepared in a 1.7 ml eppendorftube that 
contained the following: 20 J.d SP6 Transcription 5X buffer; 27.5 ~1 rNTP mix (5 ~I each 
lOOmM rATP, 100 mM rCTP, l OOmM rUTP, 2.5 ~llOOmM rGTP and 10 ~130mM CAP 
analogue); 10 ~I Enzyme Mix, SP6 RNA Polymerase. To this mix 15 J.Ll linear DNA 
template was added and the volume made up to 100 ~I with DEPC-treated water. The 
reaction mixture was gently pipetted to mix and then incubated at 37°C for 3 hours. At 
the end of the incubation, the DNA template was removed by digestion with RQ I RNase-
free DNase. RQ 1 was added to the reaction tube to a concentration of l U per l ~g of 
initial DNA template and incubated at 3 7°C for 15 minutes. After incubating, 150 J.Ll of 
DEPC-treated water is added to each tube. This is followed by extraction with equal 
volume ofPhenol/CWorofonn!IAA. The aqueous phase was transferred to a new 1.7 ml 
eppendorf tube and the linear DNA template was precipitated with 2.5X the volume of 
ice cold 100% ethanol and 1/10 the volume of 3M NaOAc at -20°C for 30 minutes. The 
RNA was then collected by centrifugation, washed with cold 70% ethanol, dried under 
vacuum and resuspended in 100 ~I DEPC-treated water. 
Spectrophotometric Quantitation. The final concentration of the resuspended eRN A 
was determined through spectrophotometric quantitation. Readings for 300 and 600 fold 
dilutions of cRNA were prepared and the absorbance read at 260 run and 280 nm 
wavelengths (A260 and A2so). One A260 unit equals 40 ~glml of RNA and the ratio of A 260 
and A2so readings should equal 2.0 barring the presence of contaminating protein or 
phenol. 
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2.3 In Vitro Coupled Transcription-Translation 
Materials: TNT™ SP6 Coupled Reticulocyte Lysate System was purchased from Promega 
Corporation. 2X SSB contains 5ml stacking gel buffer (0.5M Tris, pH 6.8), 5ml 
20%SDS, 2.5 ml P-mercaptoethanol (BDH Inc., Toronto, Ontario), 5 mJ glycerol, 5 ml 
dH20 and a few bromophenol blue crystals. 
Method: The in vitro transcription-translation reaction mixture contained 12.5 )..ll TNTTM 
Rabbit Reticulocyte Lysate, I )..ll TNTTM Reaction Buffer, 0.5 )..ll 1 mM Amino Acid 
Mixture minus Methionine, 0.5 )..ll RNAguard, 1 )..lg FGFR cRNA, 2 )..ll 35S-methionine 
(PerkinEimer Canada Inc., Woodbridge, Ontario) and DEPC-treated water to a final 
volume of25 )..ll. TNTTM SP6 RNA Polymerase was omitted from this reaction since the 
starting material was an RNA sample and therefore the transcription step was not 
required. The reaction mixture was incubated at 30°C for 90 minutes. Determination of 
percent incorporation of the radioactive label analysis and sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-P AGE) analysis of the translation products 
were conducted. 
2.3.1 Determination of Incorporation of Radioactive Label 
Method: 2 )..ll of the above translation products and 98 )..ll of 1 N NaOH/ 2% H20 2 ( 1 00 )..ll 
I ON NaOH, 67 )..ll 30% H20 2 and sterile dH20 to 1000 )..ll fmal volwne) were mixed by 
vortexing and incubated at 37°C for 10 minutes. Following the incubation 900 )..ll of ice 
cold 25%TCA/2% Casamino acids were added to precipitate the translation product, this 
mixture was incubated on ice for 30 minutes. The precipitated translation product was 
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then collected on Whatman GF/A glass fiber filters under vacuum and washed 3X with 
1ml ice cold 5%TCA followed by 1 ml ice cold 100% ethanol. The filter was allowed to 
dry under vacuum. For determination of35S incorporation, the filter was placed in 3 ml 
of scintillation fluid in a glass scintillation vial and counted in a Beckman LS 3801 liquid 
scintillation counter. 
2.3.2 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Method: 5 Jll of the above translation products and 30 Jll of 1.5X SSB (sample buffer) (3 
parts 2X SSB and 1 part dH20) were mixed. An 8% SDS-Polyacrylamide gel (Table 2.4) 
is topped with a Stacking gel (Table 2.5) and set with a comb to form the wells into 
which the samples are loaded. Samples were denatured for 5 minutes in a boiling water 
bath and then loaded onto the gel. Electrophoresis was performed for 1.5 hours at a 
constant current of 30mA supplied by BIO-RAD Model 1000/500 Power Supply until the 
blue dye front migrated to the bottom edge of the gel. The gel was then fixed (Table 2.6) 
for 15 minutes, destained (Table 2.6) for additional 15 minutes and finally soaked in 
Amplify (Amersham) for 30 minutes. The gel was then transferred to a small piece of 
Whatman 3mm Chromatography paper and dried at 80°C under vacuum for 1.5 hours. 
The dried gel was exposed to X-ray film (Kodak X-AR film), overnight at room 
temperature in a Fisher Biotech Electrophoresis Systems FBAC 810 autoradiography 
cassette (Fisher Scientific). Exposed films were developed using a Kodak RP X-OMAT 
Processor in the Radiology Department of the Health Sciences Centre, MUN, St. John's, 
NF. 
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Table 2.3: Composition of SDS-PAGE Running Gel. 
Per 10 ml final volume 8% 10% 12% 15% 
30% Aery/amide 2.67 ml 3.33 ml 4.0ml 5.0 ml 
Running Gel Buffer 2.5 ml 2.5 ml 2.5 ml 2.5 rnl 
20%SDS 40 ).ll 40 ).ll 40J..d 40 f.ll 
Sterile dH20 4.72ml 4.06 ml 3.39 ml 2.39 ml 
10%AP 66 ).ll 66 f.!) 66 f.ll 66 f.ll 
TEMED 4)-ll 4 f.ll 4 f.ll 4 f.ll 
Table 2.4: Composition ofSDS-PAGE Stacking Gel 
per 5 ml final volume 
30% Aery/amide 0.66 ml 
Stacking Gel Buffer 1.25 ml 
20%SDS 25 f.ll 
Sterile dH20 3.03 ml 
IO%AP 33 ).ll 
TEMED 4 ).ll 
Table 2.5: Composition of SDS-PAGE gel Fix and Destain Solutions 
Fix per 100 ml final volume Destain 
45 ml 100% Methanol 20 ml 
10 ml Glacial Acetic Acid 6ml 
45 ml dH20 74 ml 
2.4 Microinjection of Xenopus embryos. 
Materials: Microinjection apparatus was a Drummond Nanoject II Microinjector from 
Fisher Scientific, Nepean, Ontario. Microinjection needles were prepared by pulling 3.5 
inch Drummond Glass Capillary tubes (Fisher Scientific) vertically using a Narishige 
Model PB-7 micropipette puller. Needle tips were beveled at a 20° angle with a 
Narishige EG-40 grinder. An injection plate that was fashioned using chloroform to 
45 
adhere a small section of fine plastic mesh to the bottom of a 60 x 15 mm Fisher brand 
disposable petri dish was used to hold embryos in the correct orientation during 
injections. The cRNA of fibroblast growth factor receptor variants VT + and VT- were 
produced in the lab of Drs. Gillespie and Paterno, as previously described. 
Method: Synthetic VT+ and VT- cRNAs were injected into the animal pole of Xenopus 
laevis embryos at stage 1, pre-first cleavage (Figure 2.1). Through an injection volume 
of 4.6 nl, each embryo received DEPC-treated water or 10 ng of VT +eRN A, VT- eRN A. 
Embryos were placed in NAM/2 (Table 2.2) + 4% Ficoll PM400 (Arnersham Pharmacia 
Biotech) for injections and subsequent culture. The embryos were left to develop at room 
temperature until they reached the desired stage of development. 
2.5 Total RNA extraction from whole Xenopw· embryos 
Materials: TRI Reagent™ - RNA/DNA/Protein Isolation Reagent was purchased from 
Invitrogen, Carlsbad, California. 
Method: Total RNA was extracted from whole embryos as described in the TRI Reagent 
package insert. Briefly, five Xenopus embryos at the same stage of development were 
transferred to a 1. 7 ml eppendorf tube and homogenized in 1 ml TRI Reagent by pipeting 
up and down and then stored at-70°C. Phases were separated by addition of0.2ml 
chloroform per 1 ml TRI Reagent, vortexing for 15 seconds and then the tube was left at 
room temperature tor 2-1 5 minutes. Tubes were then centrifuged at 4°C, I 2,000 rpm for 
15 minutes. After centrifugation the aqueous, RNA containing phase was recovered and 
pi petted into a new 1. 7 ml eppendorf tube. The total RNA was then precipitated out of 
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solution by adding 0.5 ml isopropanol per 1ml of initial TRI Reagent volume and 
incubating the tube at room temperature for 5-1 0 minutes. Tubes were then centrifuged 
at 4°C, 12,000 rpm for 20-25 minutes. The total RNA precipitate formed a gel like pellet 
on the side and bottom of the tube. The supernatant was decanted and the total RNA was 
washed once with cold 75% ethanol by vortexing the tube and then centrifuging at 4°C, 
12,000 rpm for 10-15 minutes. The ethanol was decanted off and the washed RNA pellet 
was dried briefly under vacuum (3-5 minutes maximun) then resuspended by pipetting up 
and down in 50 f • .t.l ofDEPC-treated water. The solubilized RNA was then treated with 
RNase-free DNase RQ 1 (Promega) at 37 °C for 15-20 minutes. This was followed by 
extraction with an equal volume of Phenol/Chloroform/IAA. The aqueous phase was 
transferred to a new 1. 7 ml eppendorf tube andre-extracted with an equal volume of 
Chloroform/IAA. The aqueous layer was transferred to a new 1.7 m1 eppendorftube and 
total RNA was precipitated with 2 times the volume of ethanol and 1/ 10 the volume of 3M 
NaOAc at -20°C overnight. The total RNA was then collected by centrifugation, washed 
with cold 70% ethanol, dried under vacuum and resuspended in 30 )ll DEPC-treated 
water. I )ll RNAguard™ RNase Inhibitor (Amersham Pharmacia Biotech) was added to 
the resuspended RNA and stored at -70 °C. 
2.6 Reverse transcription of mRNA from Xenopus laevis embryos 
Materials: Random primer oligonucleotide (mostly hexamers- d(N)6), SX First Strand 
Buffer and Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV -RT), were 
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all purchased from Invitrogen. Dithiothreitol (DTT) was purchased from Sigma-Aldrich 
Canada Ltd., Oakville, Ontario. 
Method: 2 J.t) of d(N)6Random Primer (IOOng/J.tl) was added to 15 J.1l of the resuspended 
total RNA (2 J.tl total RNA + 13 J.tl DEPC-treated water). This mixture was heated to 
70°C for I 0 minutes and then quicked cooled in an ice-water bath for a minimum of 2 
minutes. This was followed by the addition of 8 J.tl 5X first strand buffer, 2 J.tl each 
1 OmM dNTPs, 4 J.tl 1 OOmM DTT, 1 J.tl RNAguard™ RNase Inhibitor and 2 J.tl M-ML V 
reverse transcriptase. This mixture was allowed to incubate at 37°C for 60 minutes. The 
reverse transcription products were used directly in PCR reactions. 
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Figure 2.1: Stages of Xenopus laevis embryonic development that were injected (Stage 
I) and from which total RNA was collected for the RT-PCR experiments 
described (Stages 8.5, 1 0.5. 11.5 & 15). 
Stage 1: Age 0 hr; length 1.4-1.5 mm~ one cell stage 
Stage 8: Age 5 hr; length 1.4-1.5mm; medium cell blastula stage 
Stage 9: Age 7 hr; Length 1.4-l.5 mm; frne ce1l blastula stage 
Stage 10.5: Age 11 hr; length 1.4-1.5 mm~ crescent-shaped blastopore stage 
Stage 11.5: Age 12.5 hr; length 1.4-1.5 mm; large yolk-plug stage 
Stage 15: Age 17.5 hr; length 1.5-1.6 mm; early neural fold stage 
(adapted from Nieuwkoop and Faber, 1967.) 
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2. 7 PCR of reverse transcribed Xenopus embryo mRNA for known molecular 
markers. 
Materials: The PCR machine used was the Hybaid PCR Express from VWR Canlab, 
Mississauga, Ontario. lOX PCR buffer, 50mM MgCh and Platinum Taq polymerase were 
all purchased from Invitrogen. lOOmM dATP, lOOmM dCTP, IOOmM dGTP, and 
1 OOmM dTTP were purchased from Invitrogen. Primers used are presented in Table 2.3. 
Deionized formamide was prepared by mixing 50 ml formamide and 5 g Mixed Bed 
Resin (Bio-Rad Laboratories (Canada) Ltd., Mississauga, Ontario) and gently stirring for 
30 minutes at 4°C, after which it was filtered twice through Whatman No. I filter paper. 
The finished product was stored in a foil wrapped 50ml Falcon tube at -20°C. 1 OX Tris-
Borate/EDTA electrophoresis buffer (lOX TBE) in 1 L final volume contains 108 g Tris-
HCI, 55 g Boric acid, 40ml 0.5M EDT A (pH 8.0) and sterile dH20. 
Method: PCR reactions were carried out in 50 J..l.l volumes at cycling parameters outlined 
in Figure 2.2. For each molecular marker examined a PCR Master Mix was prepared that 
contained the following: l 00 J..l.l 1 OX PCR buffer; 30 J..i.l SOmM MgCh: 80 J..l.l 2.5mM 
dNTPs (25 J..i.l each lOOmM dATP, IOOmM dCTP, lOOmM dGTP, and lOOmM dTTP plus 
900 J..l.l sterile DEPC-H20); 5 J..l.l Platinum Taq polymerase; 740 J..l.l sterile dH20; 5 Jll o.-
32P-dATP (PerkinElmer); 20 J..l.l 1 OOng/J-1.1 primer I ; 20 J..l.l I OOng/J-1.1 primer 2. For each 50 
J-1.1 PCR reaction, 48 J-1.1 of this Master Mix was added to a thin walled PCR tube 
containing 2 u1 of Reverse Transcription products that were described previously. After 
cycling was completed, PCR reactions were inactivated by the addition of 50J.tl STOP 
buffer (in final volume 10 ml, 400 J..l.l 0.5M EDTA; 9.6 ml deionized formamide; 5 mg 
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Xylene Cyanol (810-RAD); 5 mg Bromophenol blue (BDH)). The PCR products were 
separated by electrophoresis on 6% acrylamide DNA sequencing gels. 
2.7.1 Electrophoretic Separation ofthe PCR products 
The PCR reaction/STOP buffer mixture was denatured at 80°C-90°C for a minimum of 3 
minutes. 4 J.tl was then loaded onto a 6% acrylamide DNA sequencing gel (in 1 OOml 
final volume, 6% sequencing mix contains 48 g Urea, 15 ml 40% 19: 1 acrylamidelbis-
acrylamide (810-RAD), 10 ml 1 OX TBE and up to final volume with sterile dH20). 70-
80 ml of sequencing gel mix was polymerized with 44 J.l.l TEMED (N, N, N', N' -
tetramethylethylenediamine) and 440 J.l.llO% electrophoresis grade ammonium persulfate 
(0.1 g dry weigh in 1ml sterile dH20). This mix was poured into a BIO-RAD 38x30 
Sequi-Gen® Cell and allowed to polymerize. Electrophoresis was performed for 1.5 
hours at 70W constant power, supplied by a BIO-RAD Model3000Xi Computer 
Controlled Electrophoresis Power Supply. When electrophoresis was completed the gel 
was fixed (I L final volume of 1 0% Glacial Acetic Acid, 10% Methanol), transferred to 
filter paper (Whatman 3mm Chromatography paper, 46x57 em) and dried under vacuum 
at sooc for 1.5-2 hours. The dried gel was exposed to X-ray film (Kodak X-AR film), 
overnight at -70°C in Fisher Biotech Electrophoresis Systems FBAC 1417 
autoradiography cassette with a Fisher Biotech L-Plus intensifying screen (Fisher 
Scientific). Exposed films were developed using a Kodak RP X-OMAT Processor in the 
Radiology Department of the Health Sciences Centre, MUN, St. John's, NF. 
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Figure 2.2: PCR cycling parameters. PCR reactions consisted of 1 cycle of94°C for 5 
minutes; 22 cycles of 60°C for 1 minute, 72°C for 1 minute, and 94°C for 1 
minute (for the Histone (H4) positive control); hold at 60°C until H4 
samples removed and cycling program resumed; 4 cycles of 60°C for 1 
minute, 72°C for 1 minute, and 94°C for 1 minute (additional cycles for 
Molecular marker PCR products); 1 cycle of 60°C for 1 minute, 72°C for 7 
minutes, and 30°C for 1 second. 
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Table 2.6: Sequences of upstream and downstream oligonucleotide 
primer pairs used in RT-PCR. 
Name Sequence References 
H4-1 5' - CGG GAT AAC ATT CAG GGT ATC ACT - 3' Turner & Woodland ( 1982) 
H4-2 5' - ATC CAT GGC GGT AAC TGT CTT CCT- 3' 
BMP-4U 5' - GCA TGT AAG GAT AAG TCG ATC- 3' Koster et a/. ( 1991) 
BMP-40 5' - GAT CTC AGA CTC AAC GGC AC - 3' 
Gsc-U 5'- GAG CAA AGT GGA GGA GGC AG- 3' Blumberg eta/. ( 1991) 
Gsc-D 5'- CCC ACA TCG TGG CAC TGC TG- 3' 
Mix1-l 5' - ATG TCT CAA GGC AGA GGT - 3' Rosa ( 1989) 
Mix1-2 5'- CAC TGA CAC CAG AAT CTG - 3' 
Nog- 1 5' - AGT TGC AGA TGT GGC TCT - 3' Smith & Harland ( 1992) 
Nog-2 5' - AGT CCA AGA GTC TGA GCA- 3' 
Xbra-1 5' - CAA GGA TCG TTA TCA CCT CTG- 3' Smith eta/. (199 1) 
Xbra-2 5' - TGT GTA GTC TGT AGC AGC AG- 3' 
XFkhl-1 5' - GCA GCTCTA TTA CCG ACA AG-3' Dirksen & Jamrich ( 1992) 
XFkhl-2 5' - GCA AAA GTC TGC TCC ATT GT - 3' 
Xpo-1 5' - CAC TTA GGG ATIGGTCTC AGG AGTC -3 Sato & Sargent ( 1991 ) 
Xpo-2 5' - TGA GGG AGG GCT ATG GTC TAG G- 3' 
Xwnt-SU 5' - CGA GAG TGC CTG CAA AGT GG- 3' Christian et a/. ( 1991) 
Xwnt-80 5'-TCC GGT GGC CTC TGT TCT TC - 3' 
T3.5 5' - GGG CTG CIT TTG TGT CCG CAA T - 3' Gillespie et a/. ( 1995) 
VT3' 5' - CAT TGA TGA GCT GGA GTC CCC TG- 3' 
TJ.,(TJo l) 5' - TAG CCA ACTTGG GATGTTCTC C - 3' Gillespie et a/. ( 1995) 
XFGFRm-754 5' - TGC CATTCTTCA GCCAGG GAA G - 3' 
FRPS-5'-02 5' - CAG CTC ATC AA T GAA CTC TGG AG - 3' Gillespie et a/. (I 995) 
FRPS-3' 5' - CAG TCT GTC CCT TGC CAC TTC C- 3' 
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Chapter 3 
Results 
3.1 Overexpression ofFGFR-VT+ and FGFR-VT-
It has been demonstrated previously that the micro injection of 650 pg/nl FGFR-VT+ 
cRNA into stage 1 Xenopus embryos resulted in > 90% developing into abnormal 
tadpoles, while controls injected with 650 pg/nl FGFR-VT- cRNA or DEPC-treated H20 
developed normally (Paterno et al. 2000). The abnormal phenotype presented itself at 
10-12 hours post-injection as incomplete gastrulation resulting in an enlarged blastopore 
with a protruding yolk plug (Paterno et al. 2000). The embryos continued to develop 
with clear reductions in trunk and tail structures in the resulting tadpoles (Paterno et al. 
2000). Xbra expression had been observed, by in situ hybridization, to be undetectable or 
only very faintly detectable in embryo samples overexpressing FGFR-VT+. when 
compared to controls (Paterno et al. 2000). The primary objective of my research was to 
investigate the molecular basis of the abnormal pattern of development observed in the 
Xenopus embryos overexpressing FGFR-VT+. To accomplish this, FGFR-VT+ and 
FGFR-VT- injected embryos were analyzed by comparing the expression patterns of 
known molecular markers of mesoderm induction. 
The first step in conducting these experiments was to characterize the stocks of 
FGFRl cRNAs to ensure that they were equally well translated. To confirm the 
translational efficiency of the cRNA stock samples, microinjection experiments and 
TNT™ in vitro translation experiments were conducted. Figure 3.1 shows that when the 
cRNA samples are translated using the TNT™ Reticulocyte Lysate system, 35S-
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methionine incorporation are similar for VT + and VT- samples. Figure 3 .l A shows 
SDS-PAGE results for the translation products and no significant visual discrepancy is 
observed. Figure 3.1B displays the scintillation data of the radioactive label e5s-
methionine) incorporation levels into each sample. FGFR-VT+ incorporation of 35S-
methionine measured at an average of71499 cpm and incorporation into FGFR-VT-
averaged 76394 cpm over 6 repeated translation reactions from the stock VT+ and VT-
cRNA samples. These levels are not statistically different (p-value of 0.8799). 
Subsequently I verified that I could reproduce the reported abnormalities by 
microinjecting stage 1 embryos with 4.6 nl DEPC-H20 or 2.17 ng/ul FGFR-VT+ cRNA 
or 2.17 ng/ul FGFR-VT- cRNA. Figure 3.2 is a graphical representation of the 
phenotype data obtained. It reveals that 81.5% and 76.7% of the DEPC-H20 injected and 
FGFR-VT- overexpressing embryos developed normally, respectively, while it was 
observed that only 7.3% ofthe embryos overexpressing FGFR-VT+ form of the receptor 
developed into normal tadpoles. 
Sample embryos, representative of the developmental phenotype observed after 
microinjection with the various receptor isoform cRNAs are presented in Figure 3.3. 
Both the DEPC H20 control (Figure 3.3 A) embryos and the FGFR-VT- injected (Figure 
3.3 B) embryos display normal patterns of development. The embryos injected with 
FGFR-VT +eRN A display a range of abnormal development in the posterior portion of 
the embryo. Figures 3.3 C and D display less severe posterior truncation and splitting 
while Figures 3.3 E and F represent the more severe abnormalities observed in that the 
entire embryo posterior to the head has been truncated and twisted into an 
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in vitro translation of synthetic FGFR-VT+ and FGFR-VT- RNA. 
A. Representative electrophoretic gel of level of 35S-methionine 
incorporation in 5 J.lg ofFGFR-VT+ (VT+) and FGFR-VT- (VT-) stock 
cRNA in vitro translated. 
B. Scintillation data of 35S-methionine incorporation into each of the two 
FGFR isoforms. Values represent the average of 6 repeated translation 
reactions from stock cRNA samples. 
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Figure 3.2: Graphical representation of the phenotype expression in Xenopus embryos 
overexpressing FGFR-VT+ (VT+) and FGFR-VT- (VT-) and that of the 
DEPC-H20 (DEPC) control group. A total of 135 embryos (45 VT+, 45 
VT- and 45 DEPC) were used for each experiment, and averages and 
standard deviation (error bars) values of7 individual experiments are 
shown. Xenopus embryos at Nieuwkoop and Faber stage 40 of 
development. 
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Figure 3.3: Embryos representative of the developmental phenotype observed after 
micro injection with either of the receptor isofonn cRNAs or the control 
injection. A. DEPC H20 control injection - normal phenotype. B. FGFR-
VT- injection - normal phenotype. C- F. FGFR-VT + injection - various 
degrees of posterior truncation observed. Xenopus embryos at Nieuwkoop 
and Faber stage 40 of development. 
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undistinguishable mass of tissues. The majority of embryos injected with FGFR-VT + 
display severe reductions in trunk and tail structures. These results are in agreement with 
those reported previously by Paterno et al. (2000). 
3.2 Molecular Marker Analysis 
The primary objective of this project was to investigate the molecular basis of the 
abnormal pattern of development observed in the Xenopus embryos overexpressing 
FGFR-VT+. TotaJ RNA samples were isolated from batches of embryos injected with 
FGFR-VT-, FGFR-VT+ cRNAs or DEPC H20 (Control) at developmental stages 8.5, 
1 0.5, 1 1 .5 and 15 as described in Chapter 2: Materials and Methods (page 40). The 
embryos selected for these samples consisted of normally developing embryos from the 
controls, DEPC H20 and FGFR-VT-, and abnormally developing embryos from the 
FGFR-VT+ injection set. Embryos were sampled in this manner because we were 
investigating the possibility of gene expression differences between the abnormal and 
normal embryos that are overexpressing these two FGFR isoforms. The total RNA 
samples were reverse-transcribed into eDNA and then used for RT-PCR analysis. A 
series of Xenopus molecular markers known to have differential expression in the 
affected regions were chosen for analysis in an effort to elucidate a molecular basis for 
the observed abnormal phenotype. The amount of eDNA added to each PCR reaction 
was normalized using Histone 4 (H4). Equivalent H4 levels indicate equivalent eDNA 
input concentrations. This allowed for the comparison of samples within each marker 
primer set. With the input normalized, differences that appear in the PCR product levels 
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between samples represent differences in expression of the molecular markers, not 
differences in the overall eDNA input. This holds true provided that the PCR reaction 
has not reached a point of saturation. The PCR amplification reaction is not unlimited; 
the amplification target will gradually stop accumulating exponentially and it will enter a 
level phase known as the "plateau" (Innis and Gelfand 1990; Saiki 1989). If reactions 
have reached saturation, due to incorrect reaction parameters, then differences between 
product bands may be decreased or less obvious. 
Prior to commencing radio labeled PCR reactions, every total RNA sample collected 
and subsequently reverse transcribed was assayed initially for histone-4 (H4) expression. 
As an input control, it was empirically determined that 26 cycles produced a sufficient 
level of H4 for detection using a standard unlabeled PCR reaction. It was subsequently 
empirically determined that for radiolabeled PCR reactions, 22 cycles would produce 
sufficient levels for H4 detection and 26 cycles would produce sufficient levels of the 
molecular markers for detection. Every marker analyzed was examined in duplicate 
along with H4 input control using the labeled PCR protocol. The PCR product bands 
were analyzed by densitometry using AlphaEaseTM Stand Alone Software Version 3.2 on 
the Chemilmager 4000 Digital Imaging and Analysis System (Alpha Innotech 
Corporation) to quantify expression levels. 
BMP-4 expression levels are shown in Figure 3.4A and densitometric analysis results 
are graphically represented in Figure 3.4B. lt is shown that only subtle differences in 
expression levels were detected for BMP-4 within each stage of development for all three 
of the sample conditions. The pattern of expression between the DEPC H20 (Control) 
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Figure 3.4: A. RT-PCR analysis ofBMP-4 expression in stage 8.5, 1 0.5, 11.5 and 15 
Xenopus embryos injected with DEPC-H20 (OH) or overexpressing FGFR-
VT+ (VT+) or FGFR-VT- (VT-). Total RNA was extracted and analyzed 
from five embryos for each injection set at each stage indicated. Histone 
(H4) levels were used to normalize the eDNA input for each PCR reaction. 
PCR cycles: 22 Histone; 26 BMP-4. (Con) represents a negative control, 
PCR reaction without eDNA. B. Densitometric analysis of the expression 
level of BMP-4 normalized to I-14 for each sample presented in Figure 3.4A. 
Duplicate PCR analysis was performed on two separate injection 
experiments and a representative gel is shown above. 
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Figure 3.5: A. Rl-PCR analysis ofForkhead expression in stage 8.5. 1 0.5, 11.5 and 15 
Xenopus embryos injected with DEPC-H20 (01 I) or overexpressing FGFR-
VT• (VT+) or FGFR-VT- (VT-). Total RNA was extracted and analyzed 
from five embryos for each injection set at each stage indicated. Histone 
(I 14) levels were used to normalize the eDNA input for each PCR reaction. 
PCR cycles: 22 Histone; 26 Forkhead. (Con) represents a negative control. 
PCR reaction without eDNA. B. Densitometric analysis of the expression 
level of Forkhead normalized to 114 for each sample presented in Figure 
3.5A. DupJicate PCR analysis was performed on two separate injection 
experiments and a representative gel is shown above. 
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samples of the four stages examined followed the normal pattern of expression reported 
in the literature (Nishimatsu et al. 1992; Dale et al. 1992), i.e. BMP-4 gene expression 
begins around MBT stage 8.5, peaks during gastrulation and declines in level after that, 
however transcripts persist into early tadpole stages (stage 34). 
Xenopus Forkhead expression levels are presented in Figure 3.5A, with graphical 
representation provided in Figure 3.58. No difference in Xenopus forkhead expression 
level was detected for any of the sample conditions within each stage examined. The 
pattern of expression between the DEPC H20 (Control) samples for the stages examined 
followed the normal pattern of expression reported in the literature (Dirksen and Jamrich 
1992), i.e. gene expression commences at MBT, represented by stage 8.5, peaks between 
stages 10 and 12, and transcripts decrease from then on. 
Goosecoid expression levels are shown in Figure 3.6A, while Figure 3.68 provides 
graphical representation of the densitometry data. Goosecoid expression is barely 
detectable at stage 8.5 for all three injection samples; by stage 10.5 the expression level 
had peaked and was similar for all three samples within the stage. By visual evaluation 
of Figure 3.6A, Goosecoid levels at stage 11.5 appear to be elevated in the FGFR-VT-
injected sample when compared to FGFR-VT +and DEPC H20 (Control) samples at the 
same stage. Densitometric analysis of this sample (Figure 3.6B) revealed that the 
difference is subtle and is comparable to that observed at stage 1 0.5. By stage 15, the 
levels of expression are reduced, but the DEPC H20 (Control) sample maintains slightly 
higher expression than either FGFR-VT- or FGFR-VT+ (Figures 3.6A & B). The pattern 
of 
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Figure 3.6: A. RT-PCR analysis ofGoosecoid expression in stage 8.5, 1 0.5, 11.5 and 15 
Xenopus embryos injected with DEPC-H20 (DH) or overexpressing FGFR-
VT+ (VT+) or FGFR-VT- (VT-). Total RNA was extracted and analyzed 
from five embryos for each injection set at each stage indicated. Histone 
(H4) levels were used to normalize the eDNA input tor each PCR reaction. 
PCR cycles: 22 Histone; 26 Goosecoid. (Con) represents a negative control, 
PCR reaction without eDNA. B. Densitometric analysis of the expression 
level ofGoosecoid normalized to H4 for each sample presented in Figure 
3.6A. Duplicate PCR analysis was performed on two separate injection 
experiments and a representative gel is shown above. 
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Figure 3.7: A. RT-PCR analysis of Mix-1 expression in stage 8.5, 1 0.5, 11.5 and 15 
Xenopus embryos injected with DEPC-H20 (DH) or overexpressing FGFR-
VT+ (VT+) or FGFR-VT- (VT-). Total RNA was extracted and analyzed 
from five embryos for each injection set at each stage indicated. Histone 
(H4) levels were used to normalize the eDNA input for each PCR reaction. 
PCR cycles: 22 Histone; 26 Mix-1 . (Con) represents a negative control. PCR 
reaction without eDNA. B. Densitometric analysis of the expression level of 
Mix-1 normalized to 114 for each sample presented in Figure 3.7A. 
Duplicate PCR analysis was performed on two separate injection 
experiments and a representative gel is shown above. 
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expression in the DEPC H20 (Control) samples of the four stages examined followed the 
normal pattern of expression reported in the literature (Cho et al. 1991 ). 
Mix -1 expression levels are presented in Figure 3. 7 A and graphically represented in 
Figure 3.7B. It is shown that onJy subtle differences in expression levels were detected 
for Mix- I within each of stages 8.5, 10.5 and 11.5 for all three of the sample conditions 
and Mix-1 expression was not detected for any of the stage 15 samples. The observed 
expression pattern in the DEPC H20 (Control) samples for the stages examined 
corresponds with that reported in the literature for Mix-1, initially detected shortly after 
MBT (St. 8.5), peak expression at St. 10 and decays gradually to be undetectable by 
neurulation (Rosa 1989). 
Noggin expression levels are presented in Figure 3.8A and graphically represented in 
Figure 3.88. Noggin expression levels were similar for all three experimental conditions 
within each stage of development. The observed expression pattern in the OEPC H20 
(Control) samples for the four stages examined is consistent with that reported in the 
literature: low levels of expression in the oocytes (maternal transcripts) and higher 
expression by stage 11 due to zygotic transcription (Smith and Harland 1992). 
Xenopus Brachyury (Xbra) expression levels are shown in Figure 3.9A and graphical 
representation of the densitometric analysis is provided in Figure 3.9B. It is shown that 
no djfferences are detected in Xbra expression levels withln each stage of development 
for all three of the sample conditions. The expression pattern observed in the DEPC H20 
(Control) samples for the stages examined is consistent with that reported in the literature 
for Xbra, with it being initially detected at MBT (Stage 8.5), highest 
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Figure 3.8: A. RT-PCR analysis of Noggin expression in stage 8.5, 1 0.5, 1 1.5 and 15 
Xenopus embryos injected with DEPC-H20 (DH) or overexpressing FGFR-
VT+ (VT+) or FGFR-VT- (VT-). Total RNA was extracted and analyzed 
from five embryos for each injection set at each stage indicated. Histone 
(H4) levels were used to normalize the eDNA input for each PCR reaction. 
PCR cycles: 22 Histone; 26 Noggin. (Con) represents a negative control. 
PCR reaction without eDNA. B. Densitometric analysis of the expression 
level ofNoggin normalized to H4 for each sample presented in Figure 3.8A. 
Duplicate PCR analysis was performed on two separate injection 
experiments and a representative gel is shown above. 
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Figure 3.9: A. RT-PCR analysis of Xenopus Brachyury (Xbra) expression in stage 8.5. 
1 0.5, 11.5 and 15 Xenopus embryos injected with DEPC-H20 (DH) or 
overexpressing FGFR-VT+ (VT+) orFGFR-VT- (VT-). Total RNA was 
extracted and analyzed from five embryos for each injection set at each 
stage indicated. Histone (H4) levels were used to normalize the eDNA input 
for each PCR reaction. PCR cycles: 22 Histone; 26 Xbra. (Con) represents a 
negative control, PCR reaction without eDNA. B. Densitometric analysis of 
the expression level ofXbra normalized to H4 for each sample presented in 
Figure 3.9A. Duplicate PCR analysis was performed on two separate 
injection experiments and a representative gel is shown above. 
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expression levels occurring during gastrulation (Stage l 0.5 and 11.5) and expression 
levels declining after gastrulation into neurulation (Stage 15) (Smith et al. 1991 ). 
Xwnt-8 expression levels are presented in Figure 3.10A and Figure 3.108 provides 
graphical representation of the data. It is shown that only subtle differences in expression 
levels are detected within stages 8.5 and 10.5 of development for all three experimental 
conditions. Stage 11.5 displays an apparent decrease in Xwnt-8 expression for the DEPC 
H20 (Control) sample. At stage 15 only subtle differences are detected between the three 
experimental conditions and as expected all samples show lower expression than stage 
11 .5. The pattern of expression between the DEPC H20 (Control) samples for the four 
stages examined followed the normal pattern of expression for Xwnt-8 as reported in the 
literature. Expression is initially detected in the stage 8.5 sample (blastula), expression 
has increased dramatically by stage 10.5 (gastrula) and expression levels begin to decline 
by stage 15 (neurula) (Christian et al. 1991 ). 
Xenopus posterior (Xpo) expression levels are presented in Figure 3.11A and 
graphically represented in Figure 3.1 18. No differences are observed in Xpo expression 
levels within each stage of development for all three experimental conditions. The pattern 
of expression in the DEPC H20 (Control) samples for the stages examined followed the 
normal pattern of expression for Xpo as reported in the literature. Expression is initially 
detected around M8T (stage 8.5), expression begins increasing at the onset of 
gastrulation (stage 10.5 and 11.5) and peaks during neurulation (stage 15) (Sato and 
Sargent 1991 ). 
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Figure 3.10: A. RT-PCR analysis ofXwnt-8 expression in stage 8.5, 10.5, 11.5 and 15 
Xenopus embryos injected with DEPC-H20 (DR) or overexpressing FGFR-
VT+ (VT+) or FGFR-VT- (VT-). Total RNA was extracted and analyzed 
from five embryos for each injection set at each stage indicated. Histone 
(H4) levels were used to normalize the eDNA input for each PCR reaction. 
PCR cycles: 22 Histone; 26 Xwnt-8. (Con) represents a negative control, 
PCR reaction without eDNA. B. Densitometric analysis of the expression 
level ofXwnt-8 normalized to H4 for each sample presented in Figure 
3.1 OA. Duplicate PCR analysis was performed on two separate injection 
experiments and a representative gel shown above. 
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Figure 3.1 1 :A. RT-PCR analysis of Xenopus posterior (Xpo) expression in stage 8.5, 
10.5, 11.5 and 15 Xenopus embryos injected with DEPC-H20 (DH) or 
overexpressing FGFR-VT+ (VT+) or FGFR-VT- (VT-). Total RNA was 
extracted and analyzed from five embryos for each injection set at each 
stage indicated. Histone (1 14) levels were used to normalize the eDNA input 
for each PCR reaction. PCR cycles: 22 Histone; 26 Xpo. (Con) represents a 
negative controL PCR reaction without eDNA. B. Densitometric analysis of 
the expression level ofXpo normalized to H4 for each sample presented in 
Figw-e 3.11 A. Duplicate PCR analysis was performed on two separate 
injection experiments and a representative gel is shown above. 
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In summary, there was very little or no difference in the molecular marker expression 
pattern between the FGFR-VT+, FGFR-VT- and DEPC-treated water injected embryos 
(Table 3.1). Some of the possible reasons for this will be discussed in Section 4.1 , p. 74. 
Therefore, I did not pursue investigation of the molecular mechanisms involved in the 
abnormality caused by overexpression ofFGFR-VT+. 
T bl 31 S a e . . f k tt b f ummary o mo ecu ar mar er express10npa em o serva 1ons. 
Mole4!ular Marker Observation 
BMP-4 Subtle differences between samples; overall, the controls display 
no difference from expected pattern. 
Xenopus Forkhead No differences between samples; overal l, the controls display no 
difference from expected pattern. 
Goosecoid Subtle differences between samples; overall, the controls display 
no difference from expected pattern. 
Mix-1 Subtle differences between samples in stages 8.5, 10.5 and 11 .5, 
not expressed at stage 1 5; overall, the controls display no 
difference from expected pattern. 
Noggin Subtle differences between samples; overall, the controls display 
no difference from expected pattern. 
Xenopus brachyury No differences between samples; overall, the controls display no 
difference from expected pattern. 
Xwnt-8 Decreased expression in control sample at stage 11 .5, compared 
to VT- and VT + samples; overall, the controls display no 
difference from expected pattern. 
Xenopus posterior No differences between samples; overall, the controls display no 
difference from expected pattern. 
3.3 Expression Analysis of Additional FGFR Variant Forms 
As previously mentioned, the secondary objective of this project was to investigate 
the expression patterns of other known FGFR isoforms that may have functional 
significance. The next FGFRl variant examined differs from the reported FGFRI 
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sequence by Proline442-Serine443 deletion, an aspect of interest as the serine residue 
represents a potential phosphorylation site. The final variant examined, actually a variant 
pair, represent the a- and P-forms ofFGFR, an aspect of interest as these receptor forms 
may have different FGF binding affinities and/or specificities. To accomplish this 
analysis, total RNA samples were collected solely from normally developing Xenopus 
laevis embryos at stages 1-8, 8.5, 9, 10, 10.5, 11, 11.5, 12, 13, 16, 25,38 and 42. For this 
experiment, Xenopus eggs were obtained via artifically induced ovulation and 
subsequently in vitro fertilized, but were not otherwise manipulated until time of 
collection and processing for RNA. This RNA panel was subsequently reverse 
transcribed and used to analyze the temporal expression patterns of the FGFR isoforms 
indicated. The product bands were also analyzed by densitometry using AlphaEase TM 
Stand Alone Software Version 3.2 on the Chemilmager 4000 Digital Imaging and 
Analysis System (Alpha Innotech Corporation) to determine a ratio of expression levels 
within each stage. 
The first analysis looked at the expression of FGFR 1 isoform that differed from the 
reported sequence by the deletion ofPro442-Ser443, subsequently referred to as FGFR-PS-. 
For the purpose of this analysis, the reported sequence containing Pro442-Ser443 is referred 
to as FGFR-PS+. Figure 3.12A represents the temporal expression pattern of the FGFR-
PS+ and FGFR-PS- isoforms at the various stages throughout early Xenopus development 
previously mentioned. Duplicate PCR analysis was performed on a single set of embryo 
RNAs collected as described above. The results of this analysis compare the ratio PS-
:PS+ within each sample as indicated (Figure 3.12); for this reason, an input control such 
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as Histone-4 levels was not used in this analysis. The expression pattern observed in 
Figure 3. 12 show that during early development the PS- variant expression level is 1.3-
1.8X higher than that of the PS+ variant at the same stage of development. By stage 
11.5, the ratio of the expression level ofthe variants approaches 1.0. 
The second analysis looked at the expression of two variants ofFGFRl that involve 
differences in the immunoglobulin-like (Ig-like) domains. The use of alternative splice 
sites results in either the inclusion or exclusion of the first of the three immunoglobulin-
like domains. For the purpose of this analysis these FGFR isoforms are termed o.-FGFR 
(3 Ig-like domains) and P-FGFR (2 Ig-like domains). Using the previously mentioned 
panel of total RNA from various stages throughout early Xenopus development, the 
temporal expression of o.-FGFR and P-FGFR were examined, comparing the ratio of o.:P 
within each stag~ but not b~tw~en :stag~s, therefore an input control such as Histone 4 
was not used in this analysis. The results of this analysis (Figure 3.13) indicated that the 
o.-FGFR variant is the predominantly expressed isoform through early development 
(stages 1-13), with an expression level approximately 2.5-4.1X higher than that ofP-
FGFR. By tadpole stages (stages 38-42) the P-FGFR variant shows an increase in 
expression levels approaching that of the a-FGFR variant at the same stage of 
development, with the ratio of o.-FGFR to P-FGFR approaching 1.0. 
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Figure 3.12: A. RT-PCR analysis ofFGFR-PS+ and FGFR-PS- temporal expression 
patterns during Xenopus laevis development. Total RNA was extracted and 
analyzed from five embryos for each stage of development indicated. Stage 
numbers represent the Nieuwkoop and Faber (1967) stages of development 
from which the sample was taken; PS+. FGFR-PS+; PS-, FGFR-PS-. Duplicate 
PCR analysis was performed on a single RNA set and a representative gel is 
shown. B. Densitometric analysis of the PS-:PS+ ratio for each sample 
presented in Figure 3.12A. 
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Figure 3.13: A. RT-PCR analysis of a-FGFR and ~-FGFR temporal expression patterns 
during Xenopus /aevis development. Total RNA was extracted and analyzed 
from five embryos for each stage of development indicated. Stage numbers 
represent tbe Nieuwkoop and Faber (1967) stages of development from 
which the sample was taken. Duplicate PCR analysis was performed on a 
single RNA set and a representative gel is shown. B. Densitometric analysis 
of the a.-FGFR:~-FGFRratio for each sample presented in Figure 3.13A. a. 
a; b, ~· 
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In addition to the temporal patterns, spatial expression patterns for these variant 
FGFR isoforms were also analyzed. Total RNA samples were collected from normally 
developing Xenopus laevis embryos (stage 8.5) that were dissected into Animal Cap, 
Marginal Zone and Vegetal Cap. Total RNA was also collected from whole embryos 
from the same batch. Figure 3.14A represents the spatial expression pattern observed for 
the FGFR-PS-, FGFR-PS+, a-FGFR and ~-FGFR isoforms. The results of this analysis 
suggest that FGFR-PS- is the predominant form in the Animal cap tissues being 
expressed at approximately 1.8X higher levels (Figure 3.148) when compared to FGFR-
PS+. The ratio of FGFR-PS- to FGFR-PS+ expression levels approaches 1.0 in both the 
Marginal zone and Vegetal cap tissues (Figure 3.148). The expression in the whole 
embryo sample suggests that FGFR-PS- is expressed at a higher level (~1.8x) than the 
FGFR-PS+ form (Figure 3.148). The spatial expression patterns ofa-FGFR and 13-FGFR 
presented in Figure 3.14A indicate that the a-FGFR variant is predominantly expressed in 
all three spatial zones examined as well as the whole embryo sample. The expression 
levels of a-FGFR are approximately 2.5-3.5X higher than the P-FGFR isoform 
expression levels (Figure 3.148) for all four samples examined. The potential 
implications of these findings will be discussed later. 
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Figure 3.14: A. RT-PCR analysis ofa.-FGFR, ~-FGFR, FGFR-PS+ and FGFR-PS-
spatial expression patterns. Total RNA was extracted and analyzed from 
animal caps (Animal), marginal zone (Marginal), vegetal caps (Vegetal) and 
whole embryos (Embryo). Histone (H4) levels were used to normalize the 
eDNA input for each PCR reaction. PS+, FGFR-PS+; PS-. FGFR-PS-. 
Duplicate PCR analysis was performed on a single RNA set and a 
representative gel is shown. B. Densitometric analysis of the PS-:PS+ ratio 
and the a-FGFR:~-FGFR ratio for each sample presented in Figure 3.14A. a, 
a; b, ~· 
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Chapter 4 
Discussion 
4.1 Molecular Marker Expression Analysis of Embryos Overexpressing FGFR-VT-
and FGFR-VT+. 
The abnormal phenotype observed in Xenopus embryos overexpressing FGFR-VT + 
may be a consequence of a deficiency in mesoderm formation (Paterno et al. 2000), 
therefore the markers being studied all represent early markers of mesoderm induction 
(Table 4.1). The set of markers representing various regions of the mesoderm were 
assessed for potential deviations from normal expression patterns, in an effort to elucidate 
the molecular pathway that was adversely affecting development in the embryos 
overexpressing FGFR-VT+. 
Table 41 R · . egaon o fE xpress10n 0 e o ecu ar fth M I M k E ar ers . d xamme . 
Marker Expressed in 
BMP-4 Ventral-lateral mesoderm 
Xenopus Forkhead Organizer 
Goosecoid Organizer 
Mix-1 Presumptive endoderm and mesoderm 
Noggin Organizer 
Xenopus brachyury Early mesoderm 
Xwnt-8 Ventral-lateral mesoderm 
Xenopus posterior Posterior mesoderm 
As previously stated, the complete set of markers examined for this project displayed 
only subtle deviations from their normal, expected pattern of expression. This may in 
part be due to any one or combination of factors, such as: no effect on this particular set 
of markers, or limitations on the methodology employed, or consistency of the RNA 
sample. 
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It is conceivable that there is no effect on any of the markers in the set evaluated. 
However, this was not anticipated as Xbra expression had previously been observed to be 
undetectable or only very faintly detectable in embryo samples overexpressing FGFR-
VT +, when compared to controls, as determined by in situ hybridization (Paterno et al. 
2000). It poses some question as to whether or not the RT-PCR results for the remaining 
molecular markers are reliable. Additional means of re-examining these markers might 
include procedures such as whole mount in situ hybridization, northern blot analysis, or 
RNase protection assay. These procedures will be discussed in further detail in the 
potential future directions of this research, Section 4.3.1, p.8l. 
Limitations on the methodology used include translational efficiency; RNA may be 
present but is it translated? The RT-PCR procedure would amplify RNA that is present 
but the question of whether or not this RNA is being translated into protein in vivo 
remains. In addition, the RT-PCR procedure amplifies target messages as well as any 
errors or contaminations present, subsequently affecting the accuracy and reliability of 
the data. Therefore, consistency of the RNA sample collected represents another possible 
limitation. This project investigated the molecular basis of the abnormal phenotype 
observed in embryos overexpressing FGFR-VT +. Therefore embryos collected were 
phenotypically nom1al for the control samples (DEPC-H20 and FGFR-VT- injected 
embryos) and phenotypically abnormal for experimental samples (FGFR-VT +injected 
embryos). The reason for this selection method is that we were looking directly at the 
RNA pool of these embryos for possible gene misexpression, that is differences in gene 
expression patterns between the control (normal) and experimental (abnormal) embryos. 
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The potential for a problem presents itself in that if a single normal embryo is collected 
with the abnormal sample, it may "contaminate" this sample with copies of genes that are 
being misexpressed in the abnormal embryos. The methodology employed, radio labeled 
RT-PCR would amplify these normal copy genes and the expression pattern presented 
would not be a truly representative pattern. The reason that this represents a possible 
problem is that the abnormal phenotype does not present until gastrulation at which time 
it can present as a severely abnormal exogastrulation event or as a subtle slowing of 
gastrulation movements. All embryos collected prior to gastrulation appear normal and 
as development proceeds to gastrulation and beyond, abnormal development becomes 
obvious. While much care was taken during sampling to avoid this, it remains as a 
possible reason for lack of differences observed. Furthermore, PCR analysis may have 
been too sensitive a method to employ in analyzing marker expression under the 
sampling protocol implemented, i.e. for pooled embryo samples. Subsequent analysis 
should consider the plausibility of sampling individual embryos as controls or for 
comparison to pooled embryo samples. 
4.2. Expression Pattern Analysis ofFGFR Variant Forms. 
4.2.1 Analysis FGFR-PS+ and FGFR-PS- Isoforms. 
Study into the expression pattern of this variant pair was undertaken as Serine443 
represents a potential phosphorylation site and therefore differential expression of these 
isoforms may be functionally significant. As determined by NetPhos 2.0 predictions, 
amino acid position 443, occupied by serine residue in the PS+ variant is located within a 
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phosphorylation consensus sequence (Blom et al. 1999). Comparison with consensus 
sequences for several Ser/Thr kinases revealed that amino acid position 443 was located 
within a consensus sequence for phosphorylation by PKA (Kennelly and Krebs 1991). In 
FGFR-PS+, a serine is located in position 443, however in the FGFR-PS- form a Lys 
occupies this position. 
Temporal expression of FGFR-PS variants revealed that the PS- variant is the 
predominant form up until stage 11.5 after which time little or no difference in expression 
levels between the two forms is detected. The spatial expression analysis revealed that 
the PS- variant is the predominant form present throughout the stage 8.5 embryo. This 
raises question into the possibility of functional differences between these receptor 
isoforms. 
It has been previously demonstrated for receptor isoforms that differ from each other 
by a dipeptide sequence, FGFR-VT+ and FGFR-VT-, when one of these amino acids 
positions falls into a phosphorylation consensus site, the isoforms can differ in their 
ability to be regulated by phosphorylation (Gillespie et al. 1995). Phosphorylation 
represents an important mechanism for regulating FGFR activity, for this reason these 
variants, FGFR-PS+ and FGFR-PS- may function differently in addition to being 
expressed differently. To date there is no evidence in the literature for a differential role 
of these isoforms (PS+ and PS-) during mesoderm induction specifically or during 
development in general. 
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4.2.2 Analysis of a-FGFRl and Ji-FGFRl Forms. 
The expression analysis of the FGFRl variants that differ in their number of 
immunoglobulin-like (lg-like) domains, the a-form (3 lg-like domains) and the P-form (2 
lg-like domains) is of interest because they may also differ in their ligand binding 
specificities and affinities. The second Ig loop, the linking sequence and the NH2 
terminus of the third Ig loop comprise the minimal structural requirement for the binding 
ofFGF family ligands in general. The COOH-terminus of the alternatively spliced third 
Ig loop determines the specificity for particular FGFs (Wang et at. 1995a; Wang et al. 
1995b). It has been demonstrated that human and rat a -FGFR shows an affinity for FGF-
1 that is 12.5 % of that of P-FGFR in the presence of heparin and shows no affinity for 
FGF-1 in the absence of heparin (Shi et al. 1993). 
The results ofthis analysis indicate that both the a-FGFRl and P-FGFRl variants are 
expressed through early development (stages 1-16), however the a-FGFRJ isoforrn 
displays a greater than 2.5-fold increase in expression level as compared to the P-FGFRl 
isoforrn during this timeline. By tadpole stages (stages 38-42) the P-FGFRl variant 
shows an increase in expression levels approaching that ofthe a-FGFRl variant at the 
same stage of development. The spatial expression pattern results indicated that the a-
FGFR 1 variant is predominantly expressed in all three spatial zones examined as well as 
the whole embryo sample. 
These results may be a consequence of ligand availability. The a-FGFRI form may 
be predominantly expressed during early stage Xenopus development in response to the 
presence ofFGFs that preferentially bind a-FGFRl. As development stages progress and 
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additional FGFs begin to accumulate, the ~-FGFR1 form may be up regulated to respond 
to these new ligands. ln evaluating the concept of differential expression of a- and ~­
FGFR 1 in the early stages of Xenopus development being related to ligand preference 
and availability, a review of current literature is required. Presently, Xenopus 
homologues ofFGFs 2, 3, 4, 8, 9 and 20 have been shown to exist and their expression 
patterns documented (Isaacs et al. 1992; Kimelman et al. 1988; Kiefer et al. 1993; Slack 
and Isaacs 1989; Tannahill et al. 1992; Kimelman and Kirschner 1987; Song and Slack 
1996; Slack et al. 1996; Christen and Slack 1997; Koga et al. 1999), these are 
summarized in Table 4.2. Unfortunately, little information seems to have been published 
in the literature to-date regarding a- or ~-FGFR binding specificity of the Xenopus 
homologues, with the sole exception ofXFGF3. XFGF3 has been shown to interact with 
a.-XFGFR2 Illb and Hie isoforms with high affinity and are suggested to be the most 
likely partner for XFGF3 at physiological conditions (Mathieu et al. 1995). The same 
report (Mathieu et al. 1995) also showed that XFGF3 affinities for mouse a- and P-
FGFR2-11Ic were very similar, which contrasts results by Shi et at. (1993) that reports 
FGF1 has an 8-fold higher affinity for ~-FGFR1 than for a-FGFR1. 
All six of the known Xenopus FGF homologues are present from gastrulation (stage 
12) to neurula (stage 16) (referenced in Table 4.2), the timeframe in which we have 
reported a-FGFRI as the predominant transcript. This could suggest that the a-form may 
be the principle receptor for these ligands. However, XFGF-2, XFGF-4, XFGF-8 and 
XFGF-20 all display decreased expression later in development when P-FGFRl is more 
abundant. This might be suggestive of the ~-FGFRI receptor being the most likely 
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partner for these FGFs. A decrease in FGF expression occurring concurrently with an 
increase in FGFR expression, would maintain a likelihood of an FGF-FGFR interaction. 
Undoubtedly, further research into the binding affinities between these prospective 
ligand-receptor partnerships will be required. 
Table 4.2: Documented Expression Patterns of Xenopus FGF Homologues. 
XenopusFGF Expression Reference(s) 
homologue 
XFGF-2 abrupt increase at MBT and maintains Kimelman et al. 1988; 
a stable level through gastrulation and Kimelman and Kirschner 1987 
neurulation. 
XFGF-3 expressed just before the onset of Tannahill et al. 1992 
gastrulation through to pre-larval 
stages. 
XFGF-4 sharp increase at onset of gastrulation Isaacs et al. 1992 
and falls after stage 12. 
XFGF-8 first strong expression in early Christian and Slack 1997 
gastrula, persists into late neurula, 
decreases at early tail bud, further 
decrease at late tailbud. 
XFGF-9 detected from early cleavage Song and Slack 1996 
(indicative of maternal expression), 
detected at neurula and tailbud stages 
as zygotically expressed. 
XFGF-20 initial detection at blastula, strongest Koga et al. 1999 
intensity at gastrula, decreases a 
neurula and continues to decrease 
subsequently. 
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4.3 Future Considerations 
4.3.1 In Investigating the Abnormal Phenotype Presented in Embryos 
overexpressing FGFR-VT+. 
This project has many different directions it can follow as a means to accomplishing 
the goal of uncovering the molecular basis of the observed abnormal phenotype in FGFR-
VT + overexpressing embryos. Presented here are some of the methodologies that might 
be considered in continuing this project. 
Characterization of the stock FGFRl cRNAs was conducted using an in vitro 
translation system. While this provided a measurement of translation in an in vitro 
system, it does not provide any information on how efficiently the message will be 
translated in vivo. A subsequent check could have been conducted using a myc-tagged 
construct which could be injected into embryos, total embryo protein could then be 
extracted from the sample extract and subjected to western analysis using an anti-myc 
antibody to determine the efficiency of in vivo translation. 
An initial step that might be considered in future work on the marker analysis is to 
increase the pool of markers being analyzed. For obvious reasons, increasing the test 
pool would increase the likelihood of uncovering a gene misexpression pattern. Some 
markers that might be considered include: chordin a gene whose expression can be 
activated by organizer-specific homeobox genes and which is initially expressed in the 
dorsal lip and subsequently tissues derived from the organizer (Sasai et al. 1994); Xnr3, is 
member of the TGF-f3 superfamily that is expressed specifically in the Spemann 
organizer (Smith et al. 1995); Xnot, a homeobox gene that is initially expressed 
throughout the embryo but whose expression becomes restricted to the organizer region 
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and presumptive mesoderm as development proceeds, transcription peaks at the onset of 
gastrulation, show a marked decrease by the end of gastrulation but remain detectable 
into tai lbud stages (von Dassow et al. 1993 ); Xcad3 is an immediate early target of the 
FGF-signaling pathway that is required for normal posterior development in Xenopus 
embryos (Isaacs et al. 1998). 
An additional consideration in detennining what other markers to study might be to 
conduct histological analysis on the embryos presenting the abnormal phenotype in an 
effort to elucidate what tissues may be missing or deformed. Observing the phenotype in 
conjunction with such a histological analysis may aid in the selection of additional 
markers to screen. As some of the FGFR-VT+ overexpressing embryos are observed to 
have what could be described as a "kink" in the spine or tail region. It is conceivable that 
this phenotype results from a disruption in a pathway that regulates bone/cartilage or 
somite development. This phenotypic observation and a histological analysis may 
provide evidence for selecting different sets of candidate molecules for analysis, such as: 
Xmyf-5 a gene expressed in dorsolateral marginal zone in early gastrula and is later 
found in the most dorsal and ventral tips of the somites (Hopwood et al. 1991); XmyoD, 
zygotic expression of XmyoD begins in early gastrula. XmyoD is shown to be restricted 
to the gastrula mesoderm and to the somites of neurulae and tail bud embryos. 
Transcription is activated following mesoderm induction, and XmyoD is early muscle-
specific response to mesoderm-inducing factors (Hopwood et al. 1989). The intital 
activation of MyoD transcription has been shown to require eFGF (Xenopus homologue 
ofFGF4) (Fisher et al. 2002). 
87 
RT-PCR offered a means of analyzing a large set of samples in a relatively short 
period. We analyzed eight known molecular marker expression patterns in three different 
embryo injection sets (FGFR-VT-, FGFR-VT+ and DEPC-H20) through four stages of 
development. As previously mentioned, additional methodologies might be employed to 
further examine this set of molecular markers. These could include, but are not limited 
to, northern blot analysis, RNase protection assay and whole mount in situ hybridization. 
Northern blot analysis can be used to determine the size and amount of any specific RNA 
and therefore represents another means of studying the collected RNA pools. RNase 
protection is a sensitive technique used for the quantitation of specific RNA from total 
cellular RNA and represents another method of studying the given RNA pool. The 
northern blot and RNase protection assays may suffer from the same potential problem as 
RT-PCR for the pooled RNA samples. Therefore whole mount in situ hybridization may 
be the preferred methodology of choice. The whole mount in situ hybridization protocol 
is more detailed and time consuming than that ofRT-PCR, in that it requires the synthesis 
of a specifically labeled nucleic acid probe, which has to then be hybridized to cellular 
RNA. However, it would provide a method of analyzing both temporal (stage of 
development) and spatial (location within the embryo) expression patterns. An additional 
advantage to whole mount in situ hybridization is that it permits analysis of individual 
embryos as opposed to a sample collected from a pool of several embryos. 
We have been focusing our analysis at the RNA level, another consideration in future 
direction of this project might be to look at the proteins encoded by the RNA. Western 
blot analysis of total protein samples from the same type of embryo injection sets as used 
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in this project could yield some findings of interest. Whole mount antibody staining for 
the products of the molecular marker genes analyzed represents another means of 
focusing on the protein level as opposed to RNA levels and pennits observation of spatial 
and temporal expression patterns in individual embryos. 
Fibroblast growth factor receptor signal transduction, like other receptor tyrosine 
kinases, results in the activation of several intracellular signaling pathways, such as, the 
phosphatidylinositol 3'-kinase (PI3'K) pathway, the phospholipase C gamma 1 (PLCyl) 
pathway and the Ras/MAP kinase pathway (Ryan et al. 1998; Huang et al. 1995; 
Umbhauer et al. 2000). Using methodologies to analyze an embryo sample for proteins 
known to be phosphorylated (activated) in these pathways via FGFRl signaling, such as 
MAP kinases for which phospho-specific antibodies are available, one could narrow the 
potential search field by detennining the precise pathway(s) involved. 
These pathways might also be a consideration for a VT +rescue experiment. Such an 
experiment would be designed to detennine if activation of the FGF-FGFR signaling 
pathway, initiated at a point below the receptor could rescue embryos overexpressing the 
FGFR-VT+ fonn of the receptor to develop with a nonnal phenotype. 
4.3.2 In Analyzing FGFR-PS+ and FGFR-PS- Variant Forms. 
In continuing investigation into the characterization of the FGFR-PS+ and FGFR-PS-
receptor forms, a similar approach to that taken by Gillespie et al. (1995) might be 
utilized. Analysis to determine if the predicted phosphorylation site (Ser443) is in fact 
phosphorylated will be required. A strategy that could be used to investigate this 
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possibility would be to immunoprecipitate the FGFR I from whole embryos under non-
denaturing conditions and follow this with Western blotting employing an antibody that 
recognizes phosphoserine (eg., monoclonal Anti-Phosphoserine available from Sigma). 
Should it be shown that Ser443 is indeed phosphorylated in vivo, subsequent functional 
assays would be required to ascertain any functional differences between the isoforms 
due to the presence or absence of this residue. 
4.3.3 In Analyzing the a-FGFRJ and IJ-FGFRl Forms. 
In further evaluating the concept of differential expression of a.- and~- XFGFRI 
being related to ligand preference and availability in the early stages of Xenopus 
development, binding assays should be conducted to determine if the isoforms display 
any preference for particular Xenopus FGFs. As the PCR analysis conducted for this 
project distinguished only between a.- and~- XFGFRI , additional analysis to distinguish 
between the a.-XFGFRl-IIIb and illc forms and between ~-XFGFRl-llfb and Illc forms 
might be an important consideration. Finally, injection experiments using in vitro 
synthesized cRNA of the a.- and ~- XFGFR isoforms could be undertaken to determine, 
if any, the developmental effects of overexpressing the a.- or the ~-XFGFR isoforms in 
Xenopus embryos. As the results presented in this thesis suggest that a.-FGFR is the 
predominantly expressed isoform through early development, the effect of 
overexpressing the ~-form might be of some significance. Hypothetically speaking, if the 
a.-form is the functional form during early development, overexpressing the ~-form 
might saturate the system, resulting in primarily a.-~ heterodimeric complexes instead of 
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functional a.-a. homodimeric complexes. If this was the case, one might expect to 
observe developmental abnormalities in the ~-FGFR overexpressing embryos. 
While investigated as individual isoforms, it is important to point out that the 
variations discussed may occur in any number of combinations, such as a-FGFR-
IllcNT+/PS- or ~-FGFR-IIIbNT-/PS+, for example. Currently, it is not known which 
particular combinations are expressed during development. However, this represents an 
important question for further research as differential expression of such receptor 
isoforms may provide a more precise means of regulating developmental events. 
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